In some instances, it may be desirable to dilate an anatomical passageway in a patient. This may include dilation of ostia of paranasal sinuses (e.g., to treat sinusitis), dilation of the larynx, dilation of the Eustachian tube, dilation of other passageways within the ear, nose, or throat, etc. One method of dilating anatomical passageways includes using a guide wire and catheter to position an inflatable balloon within the anatomical passageway, then inflating the balloon with a fluid (e.g., saline) to dilate the anatomical passageway. For instance, the expandable balloon may be positioned within an ostium at a paranasal sinus and then be inflated, to thereby dilate the ostium by remodeling the bone adjacent to the ostium, without requiring incision of the mucosa or removal of any bone. The dilated ostium may then allow for improved drainage from and ventilation of the affected paranasal sinus. A system that may be used to perform such procedures may be provided in accordance with the teachings of U.S. Pub. No. 2011/0004057, entitled “Systems and Methods for Transnasal Dilation of Passageways in the Ear, Nose or Throat,” published Jan. 6, 2011, now abandoned, the disclosure of which is incorporated by reference herein. An example of such a system is the Relieva® Spin Balloon Sinuplasty™ System by Acclarent, Inc. of Menlo Park, Calif.
A variable direction view endoscope may be used with such a system to provide visualization within the anatomical passageway (e.g., the ear, nose, throat, paranasal sinuses, etc.) to position the balloon at desired locations. A variable direction view endoscope may enable viewing along a variety of transverse viewing angles without having to flex the shaft of the endoscope within the anatomical passageway. Such an endoscope that may be provided in accordance with the teachings of U.S. Pub. No. 2010/0030031, entitled “Swing Prism Endoscope,” published Feb. 4, 2010, now abandoned, the disclosure of which is incorporated by reference herein. An example of such an endoscope is the Acclarent Cyclops™ Multi-Angle Endoscope by Acclarent, Inc. of Menlo Park, Calif.
While a variable direction view endoscope may be used to provide visualization within the anatomical passageway, it may also be desirable to provide additional visual confirmation of the proper positioning of the balloon before inflating the balloon. This may be done using an illuminating guidewire. Such a guidewire may be positioned within the target area and then illuminated, with light projecting from the distal end of the guidewire. This light may illuminate the adjacent tissue and thus be visible to the naked eye from outside the patient through transcutaneous illumination. For instance, when the distal end is positioned in the maxillary sinus, the light may be visible through the patient's cheek. Using such external visualization to confirm the position of the guidewire, the balloon may then be advanced distally along the guidewire into position at the dilation site. Such an illuminating guidewire may be provided in accordance with the teachings of U.S. Pub. No. 2012/0078118, entitled “Sinus Illumination Lightwire Device,” published Mar. 29, 2012, now U.S. Pat. No. 9,155,492, issued on Oct. 13, 2015, the disclosure of which is incorporated by reference herein. An example of such an illuminating guidewire is the Relieva Luma Sentry™ Sinus Illumination System by Acclarent, Inc. of Menlo Park, Calif.
While several instruments and procedures have been made and used for treatment of anatomical passageways in a patient, it is believed that no one prior to the inventors has made or used the invention described in the appended claims.
While the specification concludes with claims which particularly point out and distinctly claim the invention, it is believed the present invention will be better understood from the following description of certain examples taken in conjunction with the accompanying drawings, in which like reference numerals identify the same elements and in which:
The drawings are not intended to be limiting in any way, and it is contemplated that various embodiments of the invention may be carried out in a variety of other ways, including those not necessarily depicted in the drawings. The accompanying drawings incorporated in and forming a part of the specification illustrate several aspects of the present invention, and together with the description serve to explain the principles of the invention; it being understood, however, that this invention is not limited to the precise arrangements shown.
The following description of certain examples of the technology should not be used to limit its scope. Other examples, features, aspects, embodiments, and advantages of the technology will become apparent to those skilled in the art from the following description, which is by way of illustration, one of the best modes contemplated for carrying out the technology. As will be realized, the technology described herein is capable of other different and obvious aspects, all without departing from the technology. Accordingly, the drawings and descriptions should be regarded as illustrative in nature and not restrictive.
It will be appreciated that the terms “proximal” and “distal” are used herein with reference to a clinician gripping a handpiece assembly. Thus, an end effector is distal with respect to the more proximal handpiece assembly. It will be further appreciated that, for convenience and clarity, spatial terms such as “top” and “bottom” also are used herein with respect to the clinician gripping the handpiece assembly. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and absolute.
It is further understood that any one or more of the teachings, expressions, versions, examples, etc. described herein may be combined with any one or more of the other teachings, expressions, versions, examples, etc. that are described herein. The following-described teachings, expressions, versions, examples, etc. should therefore not be viewed in isolation relative to each other. Various suitable ways in which the teachings herein may be combined will be readily apparent to those of ordinary skill in the art in view of the teachings herein. Such modifications and variations are intended to be included within the scope of the claims.
I. Overview of Exemplary Dilation Catheter System
The distal end of dilation catheter (20) includes an inflatable dilator (22). The proximal end of dilation catheter (20) includes a grip (24), which has a lateral port (26) and an open proximal end (28). Dilation catheter (20) includes a first lumen (not shown) that provides fluid communication between lateral port (26) and the interior of dilator (22). Dilator catheter (20) also includes a second lumen (not shown) that extends from open proximal end (28) to an open distal end that is distal to dilator (22). This second lumen is configured to slidably receive guidewire (50). The first and second lumens of dilator catheter (20) are fluidly isolated from each other. Thus, dilator (22) may be selectively inflated and deflated by communicating fluid along the first lumen via lateral port (26) while guidewire (50) is positioned within the second lumen. In some versions, dilator catheter (20) is configured similar to the Relieva Ultirra™ Sinus Balloon Catheter by Acclarent, Inc. of Menlo Park, Calif. In some other versions, dilator catheter (20) is configured similar to the Relieva Solo Pro™ Sinus Balloon Catheter by Acclarent, Inc. of Menlo Park. Calif. Other suitable forms that dilator catheter (20) may take will be apparent to those of ordinary skill in the art in view of the teachings herein.
Guide catheter (30) of the present example includes a bent distal end (32) and a grip (34) at its proximal end. Grip (34) has an open proximal end (36). Guide catheter (30) defines a lumen that is configured to slidably receive catheter (20), such that guide catheter (30) may guide dilator (22) out through bent distal end (32). In some versions, guide catheter (30) is configured similar to the Relieva Flex™ Sinus Guide Catheter by Acclarent, Inc. of Menlo Park, Calif. Other suitable forms that guide catheter (30) may take will be apparent to those of ordinary skill in the art in view of the teachings herein.
Inflator (40) of the present example comprises a barrel (42) that is configured to hold fluid and a plunger (44) that is configured to reciprocate relative to barrel (42) to selectively discharge fluid from (or draw fluid into) barrel (42). Barrel (42) is fluidly coupled with lateral port (26) via a flexible tube (46). Thus, inflator (40) is operable to add fluid to dilator (22) or withdraw fluid from dilator (22) by translating plunger (44) relative to barrel (42). In the present example, the fluid communicated by inflator (40) comprises saline, though it should be understood that any other suitable fluid may be used. In some versions, inflator (40) is configured in accordance with at least some of the teachings of U.S. Pat. App. No. 61/725,523, entitled “Inflator for Dilation of Anatomical Passageway,” filed Nov. 13, 2012, the disclosure of which is incorporated by reference herein. Other suitable forms that inflator (40) may take will be apparent to those of ordinary skill in the art in view of the teachings herein.
As best seen in
In an exemplary dilation procedure, guide catheter (30) may first be positioned near the targeted anatomical passageway, such as a sinus ostium (O). Dilator (22) and the distal end of guidewire (50) may be positioned within or proximal to bent distal end (32) of guide catheter (30) at this stage. Guide catheter (30) is initially inserted into the nose of the patient and is advanced to a position that is within or near the ostium (O) to be dilated. This positioning of guide catheter (30) may be performed under visualization provided by an endoscope such as endoscope (60) described below. After guide catheter (30) has been positioned, the operator may advance guidewire (50) distally through guide catheter (30) such that a distal portion of the guidewire (50) passes through the sinus ostium (O) and into the sinus cavity. The operator may illuminate illumination wire (56) and lens (58), which may provide transcutaneous illumination through the patient's face to enable the operator to visually confirm positioning of the distal end of guidewire (50) with relative ease.
With guide catheter (30) and guidewire (50) suitably positioned, dilation catheter (20) is advanced along guidewire (50) and through bent distal end (32) of guide catheter (30), with dilator (22) in a non-dilated state until dilator (22) is positioned within the sinus ostium (O) (or some other targeted anatomical passageway). After dilator (22) has been positioned within the ostium (O), dilator (22) may be inflated, thereby dilating the ostium. To inflate dilator (22), plunger (44) may be actuated to push saline from barrel (42) of inflator (40) through dilation catheter (20) into dilator (22). The transfer of fluid expands dilator (22) to an expanded state to open or dilate the ostium (O), such as by remodeling the bone, etc., forming ostium (O). By way of example only, dilator (22) may be inflated to a volume sized to achieve about 10 to about 12 atmospheres. Dilator (22) may be held at this volume for a few seconds to sufficiently open the ostium (O) (or other targeted anatomical passageway). Dilator (22) may then be returned to a non-expanded state by reversing plunger (44) of inflator (40) to bring the saline back to inflator (40). Dilator (22) may be repeatedly inflated and deflated in different ostia and/or other targeted anatomical passageways. Thereafter, dilation catheter (20), guidewire (50), and guide catheter (30) may be removed from the patient.
II. Overview of Exemplary Endoscope
As noted above, an endoscope (60) may be used to provide visualization within an anatomical passageway (e.g., within the nasal cavity, etc.) during a process of using dilation catheter system (10). As shown in
Body (62) of the present example includes a light post (70), an eyepiece (72), a rotation dial (74), and a pivot dial (76). Light post (70) is in communication with the light transmitting fibers in shaft (64) and is configured to couple with a source of light, to thereby illuminate the site in the patient distal to window (66). Eyepiece (72) is configured to provide visualization of the view captured through window (66) via the optics of endoscope (60). It should be understood that a visualization system (e.g., camera and display screen, etc.) may be coupled with eyepiece (72) to provide visualization of the view captured through window (66) via the optics of endoscope (60). Rotation dial (74) is configured to rotate shaft (64) relative to body (62) about the longitudinal axis of shaft (64). It should be understood that such rotation may be carried out even while the swing prism is pivoted such that the line of sight is non-parallel with the longitudinal axis of shaft (64). Pivot dial (76) is coupled with the swing prism and is thereby operable to pivot the swing prism about the transverse pivot axis. Indicia (78) on body (62) provide visual feedback indicating the viewing angle. Various suitable components and arrangements that may be used to couple rotation dial (74) with the swing prism will be apparent to those of ordinary skill in the art in view of the teachings herein. By way of example only, endoscope (60) may be configured in accordance with at least some of the teachings of U.S. Pub. No. 2010/0030031, now abandoned, the disclosure of which is incorporated by reference herein. In some versions, endoscope (60) is configured similar to the Acclarent Cyclops™ Multi-Angle Endoscope by Acclarent, Inc. of Menlo Park, Calif. Other suitable forms that endoscope (60) may take will be apparent to those of ordinary skill in the art in view of the teachings herein.
III. Exemplary Port for Ethmoid Sinus
The ethmoid sinus (ES) includes ostia (not shown) for providing fluid communication to and from the cells of the ethmoid sinus (ES) and the nasal cavity. For instance, ostia may provide fluid paths for cells within the anterior ethmoid sinus (AES), cells within the posterior ethmoid sinus (PES), and the ethmoid bulla (EB). In some instances, suprabullar cells of the ethmoid sinus (ES) drain into the ethmoid bulla (EB). Some suprabullar cells may drain directly into the retrobullar space (RBS). The ethmoid bulla (EB) may itself provide fluid communication with the nasal cavity via one or more ostia, such that the ethmoid bulla (EB) may provide a fluid communication path between the other ethmoid sinus (ES) cells (that drain into the ethmoid bulla (EB)) and the nasal cavity. For instance, the ethmoid bulla (EB) may provide fluid communication through an ostium at the retrobullar space (RBS). The fluid communication paths provided by ostia may allow the entry of air and liquids (e.g., medications); while also allowing drainage of mucus. In some instances, the ostia may become blocked, may become functionally closed due to mucosal thickening, or may otherwise not provide sufficient fluid communication. In addition or in the alternative, the configuration of the retrobullar space (RBS) may impede flow through the ostium of the ethmoid bulla (EB).
The anatomy of the ethmoid sinus (ES) may make it impractical to perform a dilation procedure on ostia of the ethmoid sinus (ES) using dilation catheter system (10) to improve fluid communication within the ethmoid sinus (ES). This may lead some operators to perform an ethmoidectomy, which is an invasive procedure that involves removal of ethmoid sinus (ES) portions (e.g., tissue and bone) using an instrument such as a debriding instrument. This kind of procedure may be somewhat crude an inelegant, resulting in removal of significant amounts of mucosa that might otherwise benefit the patient. Ethmoidectomy procedures may also have risks of inadvertent damage to optic nerves, damage to orbital muscles, damage to olfactory bulbs, damage to other anatomical structures, and even leakage of cerebrospinal fluid. Even in successful ethmoidectomies, the patient may need to return for several follow-up debridements. It may therefore be desirable to improve fluid communication from within the ethmoid sinus (ES) to the nasal cavity without resorting to a procedure like an ethmoidectomy. In some instances, this may involve implantation of a port in one or more cells of the ethmoid sinus (ES). Several merely illustrative examples of such ports are described in greater detail below, while other examples will be apparent to those of ordinary skill in the art in view of the teachings herein.
A. Exemplary Port with Single Wall Deployment
Once positioned at the ethmoid bulla (EB), instrument (100) may be advanced against the ethmoid bulla (EB) such that tip (102) pierces the wall of the ethmoid bulla (EB), allowing opening (104) to be positioned within the ethmoid bulla (EB) as shown in
After instrument (100) has pierced the ethmoid bulla (EB), instrument (100) may deploy a port (200) within the opening created in the wall of the ethmoid bulla (EB) by tip (102), as shown in
Port (200) of the present example comprises a cylindraceous body (202), a first flange (204) at one end of body (202), and a second flange (206) at the other end of body (202). Body (202) is hollow and defines a lumen (208) extending from flange (204) to flange (206). As shown in
Port (200) may be formed of a resilient material, such that port (200) is compressed while port (200) is within instrument (100); with port (200) resiliently assuming the rivet like shape shown in
It should be understood that, once port (200) has been deployed, lumen (208) enables the substantially free communication of air/mucus/etc. into and out of the ethmoid bulla (EB). Port (200) thus serves as a substitute or supplemental ostium for the ethmoid bulla (EB). In some instances, the patient may be instructed to periodically self-administer medications or other fluids within their nose after a port (200) has been implanted. By way of example only, such fluids/medications may include saline, a combination of saline and a surfactant, an anti-inflammatory (e.g., mometasone, etc.), an antibiotic, an anti-fungal, and/or various other kinds of fluids/medications, including combinations thereof. Lumen (208) may provide a substantially clear path for such fluids/medications to reach the mucosa within the ethmoid bulla (EB), in addition to providing a vent/drainage path for the ethmoid bulla (EB). In other words, the presence of port (200) may provide substantially greater communication of the administered fluids/medications to the ethmoid bulla (EB) than the communication that would be provided in the absence of port (200). In some variations, a sleeve (not shown) extends from flange (206) and is in fluid communication with lumen (208). Such a sleeve may be directly coupled with a fluid delivery device and/or a suction device to actively deliver fluid or suction to the ethmoid bulla (EB) via port (200). In addition or in the alternative, such a sleeve may provide a wicking function similar to the various wicks described in greater detail below.
Next, the operator may advance a dual mode catheter (330) through cannula (320) into the ethmoid bulla (EB) as shown in
After dual mode catheter (330) has been used to flush out the ethmoid bulla (EB), a port (200) may be deployed in the wall of the ethmoid bulla (EB) via cannula (320), as shown in
B. Exemplary Port with Dual Wall Deployment
In some instances, it may be desirable to provide more than one effective supplemental ostium in the ethmoid bulla (EB). Providing a plurality of effective supplemental ostia in the ethmoid bulla (EB) may further promote fluid communication into and out of the ethmoid bulla (EB). In some instances, this may be accomplished by deploying a plurality of ports (200) as described above in different locations in the ethmoid bulla (EB). Alternatively, a single port may provide a plurality of effective supplemental ostia in the ethmoid bulla (EB).
Once distal end (404) has been positioned within the ethmoid bulla (EB), a second piercing member (410) is advanced distally out of distal end (404) as shown in
After second piercing member (412) has been actuated to form the second opening in the wall of the ethmoid bulla (EB), instrument (400) deploys a port (500) in the ethmoid bulla (EB), as shown in
Port (500) of this example also includes a corrugated region (510) that serves as a length absorbing feature. In particular, corrugated region (510) is resiliently biased to assume a compressed configuration, at which port (500) has a minimum length. However, corrugated region (510) is expandable to increase the effective length of port (500). In addition to providing a variable length for port (500), corrugated region (510) allows port (500) to flex such that flanges (504, 506) may be positioned at various orientations relative to each other. Thus, port (500) may be readily installed in various positions and configurations without requiring a particular predetermined distance between flanges (504, 506) or orientation of flanges (504, 506). It should be understood that port (500) may be formed of any of the various kinds of materials described above in relation to port (200).
C. Exemplary Alternative Port Configurations
As shown in
It should also be understood that flanges (204, 206) and petals (606, 706) may be deformable, such that port (200, 600, 700) may compress into a substantially cylindraceous shape before port (200, 600, 700) is deployed in the ethmoid bulla (EB). Furthermore, some versions of port (200, 600, 700) may have flange (204, 206) or petals (606, 706) only at one end of the body of port (200, 600, 700), such that the other end of port (200, 600, 700) is substantially straight without an outwardly protruding feature.
It should be understood that ports (600, 700, 800) may be formed of any of the various kinds of materials described above in relation to port (200). Various other suitable forms that an ethmoid port may take will be apparent to those of ordinary skill in the art in view of the teachings herein. Furthermore, while the foregoing examples are provided in the context of providing a port in the ethmoid bulla (EB), it should be understood that ports may be installed elsewhere within the sinus complex, such as in the sphenoid sinus (SS), in the posterior ethmoid sinus (PES), and/or elsewhere, without necessarily also being installed in the ethmoid bulla (EB). By way of example only, an instrument may be used to form an opening in the middle turbinate vertical basal lamella (MTvBL), medial to the posterior wall of the ethmoid bulla (EB) but lateral to the lateral wall of the vertical basal lamella (MTvBL). A port may then be deployed in that formed opening. In some instances, the port may enter the superior meatus, medial to the posterior ethmoid sinus (PES) cells. In some other instances, the port may enter the anterior-most cell of the posterior ethmoid sinus (PES). In either case, the port may serve to increase ventilation to the posterior ethmoid sinus (PES) cells and allow patient-administered substances to reach the posterior ethmoid sinus (PES) cells. Various other ways in which the above described procedures (and in some cases, instruments) may be modified to provide ports in sinus cells other than the ethmoid bulla (EB) will be apparent to those of ordinary skill in the art in view of the teachings herein.
IV. Exemplary Wick for Ethmoid Sinus
In addition to or as an alternative to deploying a port in the ethmoid bulla (EB), it may be desirable to deploy a wick in the ethmoid bulla (EB) and/or in other sinus cavities. A wick may promote communication of medical fluids to the mucosa of the ethmoid bulla (EB) through a capillary action. This capillary action may be enhanced by maximizing contact between the wick material and the mucosa in the ethmoid bulla (EB). The wick may be bioabsorbable and may itself be formed in part by a therapeutic material. Various examples of intrasinus and intersinus wicks will be described in greater detail below, while other examples will be apparent to those of ordinary skill in the art in view of the teachings herein.
Flange (1006) is configured to generally secure one end of wick (1000) relative to the wall of the ethmoid bulla (EB). It should be understood that flange (1006) may be configured similar to flange (206), similar to petals (606, 706), or in any other suitable fashion. It should also be understood that flange (1006) may simply be omitted in some versions. Flange (1006) of the present example defines an opening (1008) permitting communication of fluid through flange (1006) to reach body (1002). For instance, if a patient self-administers a fluid medication into their nose while wick (1000) is deployed in the patient's ethmoid bulla (EB), that medication may wick through body (1002) to the mucosa of the ethmoid bulla (EB). Wick (1000) thus provides a path for the medication that the medication would have otherwise not had, in order to reach the mucosa of the ethmoid bulla (EB).
If desired, a wick may span across more than one sinus cell. For instance,
Flange (1106) generally secures one end of body (1102) at an exterior wall of the ethmoid bulla (EB) while flange (1104) generally secures the other end of body (1102) at an interior wall of the sphenoid sinus (SS). Flanges (1104, 1106) may each be configured similar to flange (206), similar to petals (606, 706), or in any other suitable fashion. It should also be understood that one or both of flanges (1104, 1106) may simply be omitted in some versions. Each flange (1104, 1106) of the present example defines a respective opening (1108, 1110) permitting communication of fluid through flange (1104, 1106) to reach body (1102). For instance, if a patient self-administers a fluid medication into their nose while wick (1100) is deployed, that medication may wick through body (1102) to the mucosa of the ethmoid bulla (EB), the mucosa of the anterior ethmoid sinus (AES) cells, and the mucosa of the posterior ethmoid sinus (PES) cells; and may further reach the sphenoid sinus (SS). Wick (1100) thus provides a path for the medication that the medication would not have otherwise had, in order to reach the mucosa of the ethmoid bulla (EB), the mucosa of the anterior ethmoid sinus (AES) cells, and the mucosa of the posterior ethmoid sinus (PES) cells.
It should also be understood that wick (1100) may be installed in numerous other configurations. For instance, wick (1100) need not reach all the way to the sphenoid sinus (SS), and may instead terminate in any other sinus cell (e.g., within one of the anterior ethmoid sinus (AES) cells or one of the posterior ethmoid sinus (PES) cells, etc.). Various suitable paths for wick (1100) will be apparent for those of ordinary skill in the art in view of the teachings herein. It should also be understood that various instruments may be used to deploy wick (1100). By way of example only, an instrument similar to instrument (100) or instrument (400) may be used to deploy wick (1100). Other suitable instruments that may be used to deploy wick (1100) will be apparent to those of ordinary skill in the art in view of the teachings herein.
In some instances, a curved needle may be used to deploy a wick. For instance,
Various suitable ways in which wicking port (1300) may be deployed will be apparent to those of ordinary skill in the art in view of the teachings herein. For instance, an instrument similar to instrument (100) or instrument (400) may be used to first deploy port portion (1320), with visualization from endoscope (60) and/or some other source of visualization. After port portion (1320) is deployed in the ethmoid bulla (EB), a pair of forceps or some other instrument may be used to wrap the free end of wick portion (1310) about the anterior ridge of the middle turbinate (MT). A mandrel or other feature may be used to hold band (1318) in a straight position before wick portion (1310) is appropriately situated in relation to the middle turbinate (MT). Various other suitable instruments and methods that may be used to deploy wicking port (1300) will be apparent to those of ordinary skill in the art in view of the teachings herein. It should also be understood that port portion (1320) may be installed in a posterior ethmoid sinus (PES) cell or some other location instead of being installed in the ethmoid bulla (EB), if desired. It should also be understood that band (1318) and/or other portions of wicking port (1300) may be formed of bioabsorbable material, if desired.
While the foregoing examples are provided in the context of providing a wick in the ethmoid bulla (EB), it should be understood that wicks may be installed elsewhere within the sinus complex, such as in the sphenoid sinus (SS), in the posterior ethmoid sinus (PES), and/or elsewhere, without necessarily also being installed in the ethmoid bulla (EB). By way of example only, an instrument may be used to form an opening in the middle turbinate vertical basal lamella (MTvBL), medial to the posterior wall of the ethmoid bulla (EB) but lateral to the lateral wall of the vertical basal lamella (MTvBL). A wick may then be deployed in that formed opening. In some instances, the wick may enter the superior meatus, medial to the posterior ethmoid sinus (PES) cells. In some other instances, the wick may enter the anterior-most cell of the posterior ethmoid sinus (PES). In either case, the wick may allow patient-administered substances to reach the posterior ethmoid sinus (PES) cells. Various other ways in which the above described procedures (and in some cases, instruments) may be modified to provide wicks in sinus cells other than the ethmoid bulla (EB) will be apparent to those of ordinary skill in the art in view of the teachings herein.
V. Exemplary Expansion of Retrobullar Space
As noted above, there may be instances where the configuration of the retrobullar space (RBS) may impede flow through the ostium of the ethmoid bulla (EB). It may therefore be desirable to remodel the retrobullar space (RBS) in order to enlarge the transition zone and thereby improve fluid flow into and out of the ethmoid bulla (EB).
Once guide catheter (1400) has been suitably positioned, a balloon catheter (1410) is advanced through guide catheter (1400) as shown in
After balloon (1412) has been inflated to the point where balloon (1412) has remodeled the posterior wall of the ethmoid bulla (EB), balloon (1412) is then deflated, and catheters (1400, 1410) are withdrawn from the patient, leaving behind an enlarged retrobullar space (RBS) as shown in
It should be understood that the retrobullar space (RBS) remodeling procedure described above may be performed in addition to or in lieu of deploying ports and/or wicks as described above. It should also be understood that various other kinds of instruments may be used to perform a retrobullar space (RBS) remodeling procedure. By way of example only, catheters (1400, 1410) or instrument (1500) may be substituted with a dilation instrument as taught in U.S. patent application Ser. No. 13/832,167, entitled “Uncinate Process Support for Ethmoid Infundibulum Illumination,” now U.S. Pat. No. 9,615,959, issued on Apr. 11, 2017, the disclosure of which is incorporated by reference herein.
VI. Exemplary Retrobullar Ostium Dilation
Guide catheter (1510) of this example also includes a transversely extending reflective member (1508). Reflective member (1508) is positioned at bend (1504) and facilitates viewing of the retrobullar space (RBS) using an endoscope such as endoscope (60). In some versions, reflective member (1508) may be selectively advanced or retracted transversely relative to body (1502). Various suitable ways in which reflective member (1508) may be selectively advanced or retracted transversely relative to body (1502) will be apparent to those of ordinary skill in the art in view of the teachings herein.
Balloon catheter (1520) of the present example includes an inflatable balloon (1522) and an atraumatic tip (1524) with a rounded/tapered profile that is configured to facilitate insertion into an ostium of the ethmoid bulla (EB). In some versions, balloon catheter (1520) is configured to drive tip (1524) through an ostium when the effective inner diameter of the ostium is less than the outer diameter of tip (1524). Balloon (1522) may be configured substantially similar to dilator (22) described above. Balloon catheter (1520) may be advanced distally through (1510) to expose balloon (1522) relative to distal end (1506). Balloon (1522) may then be inflated with fluid from a fluid source (e.g., inflator (40), etc.) to expand and thereby dilate an ostium.
In an exemplary use, the operator may position guide catheter (1510) such that distal end (1506) is oriented directly toward an ostium of the ethmoid bulla (EB) from within the retrobullar space (RBS). During this positioning, the operator may direct the line of sight for endoscope (60) (or some other visualization device) at reflective member (1508) to obtain a reflected view of the posterior wall of the ethmoid bulla (EB) to visually locate the ostium. Once the guide catheter (1510) is suitably positioned, the operator may advance balloon catheter (1520) distally through guide catheter (1510) such that the tip (1524) of balloon catheter (1520) passes through the ostium. Again, this may be performed using visualization assistance from reflective member (1508). Once balloon (1522) is positioned in the ostium, balloon (1522) may be inflated with fluid (e.g., from inflator (40)) to dilate the ostium. Balloon (1522) may be held in an inflated state for any suitable duration. Balloon (1522) may be repeatedly inflated and deflated as many times as desired. Once balloon (1522) has been finally deflated, balloon (1522) may be retracted back into guide catheter (1510) and instrument (1500) may be removed from the patient's nasal cavity. It should be understood that the retrobullar ostium dilation procedure described above may be performed in addition to or in lieu of deploying ports and/or wicks as described above; and/or in addition to or in lieu of a retrobullar space (RBS) remodeling procedure as described above.
VII. Exemplary Retrobullar Piercing
In addition to or in lieu of installing a port, installing a wick, and/or enlarging the retrobullar space (RBS) by remodeling the posterior wall of the ethmoid bulla (EB), it may be desirable to drive a piercing element into the posterior wall of the ethmoid bulla (EB). In some instances, this may be done to enlarge the size of the naturally occurring ostium that is located at the posterior wall of the ethmoid bulla (EB). In addition or in the alternative, this may be done to create a new ostium for the ethmoid bulla (EB). Whether enlarging an ostium or creating an ostium, this may improve the flow of air and fluid into and out of the ethmoid bulla (EB). Various examples of instruments and procedures that may be used to pierce the posterior wall of the ethmoid bulla (EB) will be described in greater retail below, while other examples will be apparent to those of ordinary skill in the art in view of the teachings herein.
Instrument (1600) of this example further includes a piercing element (1620). Piercing element (1620) is slidably disposed within a passageway (1614) in catheter body (1602). Piercing element (1620) includes a sharp distal tip (1622). Tip (1622) is configured to pierce the wall of the ethmoid bulla (EB) without shattering the wall of the ethmoid bulla (EB). In other words, the wall of the ethmoid bulla (EB) remains intact except for the opening created by piercing element (1620), with such an opening being approximately the same size as the outer diameter of piercing element (1620). Passageway (1614) is fluidly isolated from the fluid path for balloons (1606, 1608). The distal end of passageway includes a ramp (1612) leading to transverse opening (1610). While ramp (1612) is shown as being generally planar, it should be understood that ramp (1612) may instead be curved or have some other configuration. Ramp (1612) is configured to guide piercing element (1620) generally transversely out through transverse opening (1610) when piercing element (1620) is advanced distally relative to catheter body (1602) as shown in
Once guide catheter (1700) has been suitably positioned, instrument (1600) is advanced through guide catheter (1700) as shown in
Once instrument (1600) has been suitably positioned, fluid source (1632) is actuated to drive fluid into balloons (1606, 1608), thereby inflating balloons (1606, 1608) as shown in
After balloons (1606, 1608) have been sufficiently inflated, piercing element (1620) is advanced distally as shown in
While the foregoing examples are provided in the context of piercing a wall of the ethmoid bulla (EB), it should be understood that similar procedures may be performed elsewhere within the sinus complex, such as in the sphenoid sinus (SS), or in the posterior ethmoid sinus (PES). By way of example only, an instrument may be used to form an opening in the middle turbinate vertical basal lamella (MTvBL), medial to the posterior wall of the ethmoid bulla (EB) but lateral to the lateral wall of the vertical basal lamella (MTvBL). The formed opening may serve to increase ventilation to the posterior ethmoid sinus (PES) cells and allow patient-administered substances to reach the posterior ethmoid sinus (PES) cells. Various ways in which the above described procedures (and in some cases, instruments) may be modified to create ostia for sinus cells other than the ethmoid bulla (EB) will be apparent to those of ordinary skill in the art in view of the teachings herein.
VIII. Exemplary Additional Piercing Variations
As noted above, the wall defining a sinus cavity may be pierced for various purposes, including but not limited to deploying a port, deploying a wick, or simply creating a new ostium. Several examples of instruments that may be used to pierce the wall of a sinus cavity have been described above. It should be understood that sinus wall piercing elements may include trocar type tips, coring tips, and other types of tips. Such tips may be advanced without rotation, advanced with rotation (e.g., in full rotations or angularly reciprocating partial rotations), advanced with longitudinal reciprocation (e.g., in a jackhammering action), or advanced with both rotation and longitudinal reciprocation. Piercing tips may have a sharp edge and/or an abrasive edge. As used herein, the term “piercing” should be understood to include various forms of cutting. For instance, a piercing element may also be configured to cut a slice out of a sinus wall. This may include corner slicing, medial slicing, or other forms of slicing/cutting. In some instances an act of cutting leaves a mucosal flap that can cover over exposed bone. When a cut leaves exposed bone or a tattered tissue edge, the same may be covered with a conformal material and/or curing material. Additional examples of piercing/cutting elements will be described in greater detail below; while further examples will be apparent to those of ordinary skill in the art in view of the teachings herein.
A. Exemplary Piercing Element with Serrated Edge
B. Exemplary Piercing Element with Coil
C. Exemplary Piercing Element with Curved Cutting Member
As shown in
D. Exemplary Piercing Element with Claws
As shown in
E. Exemplary Piercing Element with Helical Auger
As shown in
F. Exemplary Instrument with Helical Auger and Retractable Sheath
Handle assembly (2620) further includes a pivoting trigger (2628) that is pivotable toward and away from pistol grip (2624). As shown in
Shaft assembly (2640) extends distally from handle assembly (2620). As best seen in
A proximal end of cutter tube (2644) is integrally coupled with a sliding member (2648). As best seen in
Rotatable shaft (2646) is rotatably disposed within cutter tube (2644) such that rotatable shaft (2646) rotates independently relative to cutter tube (2644) and such that cutter tube (2644) is capable of moving longitudinally independently relative to rotatable shaft (2646). A proximal end of rotatable shaft (2646) is integrally coupled with rotatable knob (2634) such that rotation of rotatable knob (2634) causes rotation of rotatable shaft (2646) about longitudinal axis (LA1). As best seen in
The distal end of outer sheath (2642) includes an outwardly projecting annular bumper (2641). By way of example only, bumper (2641) may be formed of steel, hard plastic, soft plastic, elastomeric material, etc. Alternatively, bumper (2641) may be a unitarily formed feature of outer sheath (2642), with a radiused edge to provide outer sheath (2642) with an atraumatic distal tip. Bumper (2641) may be used to move anatomical structures (e.g., middle turbinate, uncinate process, etc.) without damaging those anatomical structures as the distal end of shaft assembly (2640) is advanced to the sinus wall (SW). Bumper (2641) may also soften any forward force that sheath (2642) might exert on the sinus wall (SW) while shaft assembly (2640) is being positioned. In some versions, bumper (2641) and/or the distal end of outer sheath (2642) may be obliquely angled relative to the longitudinal axis of outer sheath (2642) (e.g., angled from approximately 20° to approximately 70°, etc.), which may facilitate use of bumper (2641) to move tissue. It should also be understood that some versions of bumper (2641) may extend distally past the distal end of outer sheath (2642).
A distal portion of cutter tube (2644) has a tapered distal region (2643) terminating in an opening (2645) that is defined by a sharp annular edge. An auger member (2660) extends distally from a distal end of rotatable shaft (2646) such that as rotatable shaft (2646) rotates, auger member (2660) rotates as well. Auger member (2660) comprises a minor shaft (2666) having a sharp distal tip (2662) and a helical blade or flight (2664) projecting outwardly from minor shaft (2666). Minor shaft of the present example has an outer diameter of between approximately 0.04 inches and approximately 0.06 inches, though it should be understood that any other suitable outer diameter may be used. As will be discussed in more detail below, sharp distal tip (2662) may be used to penetrate the sinus wall (SW). The length of sharp distal tip (2662) may be configured to avoid inadvertent contact with other portions of sinus wall (SW). For instance, sharp distal tip (2662) may have a length of approximately 0.1 inches. Alternatively, any other suitable length may be used.
Helical flight (2664) presents an effective outer diameter (OD) that is substantially similar to an inner diameter defined by the sharp annular distal edge of cutter tube (2644). By way of example only, the inner diameter defined by the sharp annular distal edge of cutter tube (2644) may define a gap with the effective outer diameter (OD) of helical flight (2664) that is between approximately 0.0005 inches and approximately 0.002 inches. In some versions, the inner diameter defined by the sharp annular distal edge of cutter tube (2644) defines a gap with the effective outer diameter (OD) of helical flight (2664) that is less than approximately 0.005 inches. The inner diameter of cutter tube (2644) thus closely complements the effective outer diameter (OD) of helical flight (2664). Alternatively, any other suitable gap may be provided. In the present example, the gap between the inner diameter defined by the sharp annular distal edge of cutter tube (2644) and the effective outer diameter (OD) of helical flight (2664) is dimensioned to prevent any tissue from getting lodged between the inner diameter defined by the sharp annular distal edge of cutter tube (2644) and the effective outer diameter (OD) of helical flight (2664). In the present example, outer diameter (OD) is approximately 0.144 inches, though any other suitable outer diameter (OD) may be used. Also in the present example, the effective outer diameter (OD) is approximately equal to the outer diameter of major diameter proximal portion (2686). As best seen in
Auger member (2660) of the present example also defines a longitudinal gap extending longitudinally between a proximal end of helical flight (2664) and the distal end of rotatable shaft (2646). The gap between the proximal end of helical flight (2664) and the distal end of rotatable shaft (2646) of the present example has a length of approximately 0.040 inches, though it should be understood that the gap may have any other suitable length. An exterior edge of helical flight (2664) in the present example presents a flat surface (2665). Flat surface (2665) of the present example has a width between approximately 0.002 inches and approximately 0.005 inches. Alternatively, any other suitable width may be used. As will be discussed in more detail below, helical flight (2664) is configured to guide and drive auger member (2660) through an opening formed in sinus wall (SW) by sharp distal tip (2662); and to provide a structural anchor for instrument (2600) within sinus wall (SW).
1. Exemplary Operation of Instrument with Helical Auger and Retractable Sheath
As shown in
To the stage shown in
It should be understood that auger member (2660) and/or cutter tube (2644) may be driven to any depth desired. For instance, auger member (2660) and cutter tube (2644) may be driven through two or more sinus walls (SW) (e.g., along the same longitudinal path) in succession (e.g., forming a first opening in the first sinus wall (SW), then advancing distally to subsequently form a second opening in a second sinus wall (SW) after the first opening is complete, etc.). It should also be understood that, once opening (2670) has been initially formed, the operator may retract cutter tube (2644), position an edge of opening (2670) in a gap defined along the length of minor shaft (2666) between the proximal end of flight (2664) and the distal end of the major diameter portion of rotatable shaft (2646), then advance cutter tube (2644) distally to thereby take a bite out of the edge of opening (2670). This will enlarge the size of opening (2670) and may be repeated as desired in order to provide a selected size and configuration for opening (2670). Various other suitable features of instrument (2600) and methods of using instrument (2600) will be apparent to those of ordinary skill in the art in view of the teachings herein.
Although outer sheath (2642) of the present example is driven by sliding trigger (2360), it should be understood that outer sheath (2642) may be driven by other methods. For instance, outer sheath (2642) may be driven proximally, thus exposing cutter tube (2646), via rotation of rotatable knob (2634). Outer sheath (2642) may also comprise a tapered distal portion that covers auger member (2660) to thereby further facilitate insertion of shaft assembly (2640) into tight places. While sheath (2642) of the present example is rigid (e.g., formed of rigid plastic or stainless steel, etc.), outer sheath (2642) may alternatively be flexible to thereby further facilitate insertion of shaft assembly (2640) into tight places. Such a flexible outer sheath (2642) may comprise a slidable “exoskeleton” to selectively prevent flexibility when rigidity is necessary. Such a flexible outer sheath may further comprise internal features that cause outer sheath (2642) to flex outwardly as cutter tube (2646) is driven distally to avoid cutting of outer sheath (2642). It should also be understood that sheath (2642) may include detent features or similar features that provide some degree of resistance to sliding sheath (2642) when sheath (2642) is in a proximal position and/or when sheath (2642) is in a distal position. Other suitable variations will be apparent to those of ordinary skill in the art in view of the teachings herein.
2. Exemplary Alternative Retractable Sheath
Tip member (2710) may be formed of a variety of materials, including but not limited to pebax, plastic, metal, etc., including combinations thereof. Various suitable materials that may be used to form tip member (2710) will be apparent to those of ordinary skill in the art in view of the teachings herein. It should also be understood that tip member (2710) may be secured to tube (2702) in a variety of ways, including but not limited to overmolding, interference fitting, snap fitting, adhesives, welding, etc. Various suitable ways in which tip member (2710) may be secured to tube (2702) will be apparent to those of ordinary skill in the art in view of the teachings herein. In some other variations, distal edge (2407) of tube (2702) is formed at an oblique angle. In some such versions, tip member (2710) is omitted.
With sheath assembly (2700) retracted, the entire shaft assembly (2720) is advanced distally toward the sinus wall (SW), until sharp distal tip (2662) of auger member (2660) pierces the sinus wall (SW) as shown in
Having reached the stage shown in
3. Exemplary Alternative Rotatable Shafts with Helical Augers
Rotatable shaft (2680) of this example is formed in a molding process. By way of example only, rotatable shaft (2680) may be formed of molded plastic and/or metal. Other suitable materials and methods of manufacture that may be used to form rotatable shaft (2680) will be apparent to those of ordinary skill in the art in view of the teachings herein.
4. Exemplary Devices for Cleaning Helical Augers
As noted above, auger member (2660) may pick up debris such as fragments of tissue, bone, etc., after auger member (2660) has been used to form an opening (FO) in a sinus wall (SW). In some instances, it may be desirable to clean this debris from auger member (2660). By way of example only, it may be desirable to clean debris from auger member (2660) if auger member is going to be driven through another sinus wall (SW) or another region of the same sinus wall (SW), etc. In addition or in the alternative, it may be desirable to collect such debris in order to provide a tissue specimen for further analysis, as will be described in greater detail below.
Flange (2806) of the present example includes a notch (2808). While only one notch (2808) is shown, it should be understood that any other suitable number of notches (2808) may be provided. In the present example, notch (2808) has a “V” shape. In some other versions, notch (2808) has a “U” shape. Other suitable shapes that may be used for notch (2808) will be apparent to those of ordinary skill in the art in view of the teachings herein. As shown in
In some variations of instrument (2820), a foam material is used in place of bristles (2824). For instance, such a foam material may fill bore (2822), and may define a slit to facilitate insertion of auger member (2660) through the foam. As auger member (2660) rotates and/or reciprocates within bore (2822), the foam may remove debris from minor shaft (2666) and/or flight (2664). If desired (e.g., to provide a tissue specimen for further analysis), the debris that is removed by the foam may be removed from the foam.
As shown in
In the present example, web (2846) is perpendicular to gripping regions (2844), such that web (2846) is perpendicular to the longitudinal axis of auger member (2660). Put another way, web (2846) is perpendicular to a longitudinal axis of body (2842) along two dimensions (e.g., along a vertical transverse dimension and along a horizontal transverse dimension). In some other versions, web (2846) is oriented obliquely relative to gripping regions (2844) and the longitudinal axis of auger member (2660). In some such versions, web (2846) is oriented at an angle that complements the pitch angle of flight (2664). In versions where web (2846) is oriented obliquely, web (2846) may be oriented obliquely along just one dimension or along two dimensions. For instance, web (2846) may be oriented obliquely along just a horizontal transverse dimension while still being perpendicular along a vertical transverse dimension.
As yet another merely illustrative variation, body (2842) may define or otherwise include a receptacle adjacent to web (2846). Such a receptacle may be configured to catch and hold debris that is removed from auger member (2660) as auger member (2660) traverses web (2846). In some such versions, instrument (2840) may also include a cap to selectively cover the receptacle, to thereby contain the debris within the receptacle. Such a cap may be provided as a separate piece that is removably securable to body (2842). Alternatively, such a cap may be integral with body (2842), coupled thereto via a living hinge or strip of flexible material, etc. In versions with a cap (either integral or separate), the cap may include a web feature that complements web (2846) of body (2842). Thus, before auger member (2660) traverses web (2846) of body (2842), the cap may be closed down on auger member (2660) such that the web feature of the cap cooperates with web (2846) of body (2842) to remove debris from auger member (2660). It should also be understood that an instrument (e.g., a clip type of device, etc.) may include complementary pinching features that cooperate to remove debris from auger member (2660) after the pinching features are pinched onto auger member (2660), without necessarily also including a receptacle to capture the removed debris. Other suitable variations will be apparent to those of ordinary skill in the art in view of the teachings herein.
G. Exemplary Dual Piercing Elements
Instrument (2500) is operable to move arms (2504) laterally outwardly from a first position to a second position. In particular, as shown in
In any of the foregoing examples of sinus wall piercing (among other examples), it may be desirable to provide some form of structural support to the sinus wall during interaction between the sinus wall and the instrument, to reduce the risk of the sinus wall shattering to an undesirable degree during such interaction. As noted above with respect to instruments (2200, 2400, 2600), such support may be provided by the instrument itself. While curved elongate member (2202) and auger member (2410, 2660, 2682, 2692) were used in the examples above, other instrument features that may be used to provide structural support to a sinus wall during piercing will be apparent to those of ordinary skill in the art in view of the teachings herein.
In some other versions, a support material may be introduced into the sinus cavity before the act of piercing with an instrument, again to reduce the risk of the sinus wall shattering to an undesirable degree during piercing/cutting of the sinus wall. By way of example only, such support material may include a sand-like material or a hardening liquid. For instance, a hardening polymer fluid may be introduced into the sinus cavity before the act of piercing with an instrument; and may then be removed after the sinus wall has been pierced. As another merely illustrative example, a hardening biocompatible liquid may be removed with irrigation fluid once the sinus wall has been opened with a piercing element. As yet another merely illustrative example, a material that dissolves through bioabsorption or through some other process (dissolving either shortly after the sinus wall has been pierced or some time thereafter) may be used. Other examples of support material will be apparent to those of ordinary skill in the art in view of the teachings herein. Likewise, various suitable ways in which support material may be introduced to the sinus cavity will be apparent to those of ordinary skill in the art in view of the teachings herein.
In addition to or in lieu of providing a support material, the sinus wall may be frozen in order to add structural integrity to the sinus wall. By way of example only, such freezing may be provided through an applicator that is kept cold; or by the injection of a cold liquid (e.g., liquid nitrogen, etc.). As yet another alternative to providing a support material, an instrument may rely on the inertia of the sinus wall to effectively provide structural integrity. For instance, the tip of the piercing element may be advanced (and perhaps also rotated) at such a rapid rate that the inertia of the sinus wall acts as a support.
In addition to or in lieu of injecting a structural supporting material into a sinus cavity, a therapeutic material may be injected into a sinus cavity. Such therapeutic material may be injected through a naturally occurring ostium, through a natural ostium that has been enlarged (e.g., enlarged by a balloon catheter, etc.), or through a created ostium (e.g., created using any of the instruments described herein, etc.). Such a therapeutic material may be injected as a liquid that gellates once it is inside the sinus cavity. By way of example only, the gellation may be triggered by heat, by the mixing of two or more components prior to injection, by the change in shear stress following injection, by a change in pH from a pH value associated with a storage condition to a pH value associated with mucus that the liquid comes in contact with one inside the sinus cavity, and/or by other conditions.
Alternatively, a pregellated gel may be delivered to the sinus cavity. As yet another merely illustrative example, a solid or foam structure may be introduced into the sinus cavity, with a therapeutic substance being contained within the solid or foam structure. Such a solid or foam structure may be bioabsorbable or non-bioabsorbable. The inserted material may be delivered in an as-manufactured shape and size, or it may be trimmed by the surgeon at the time of delivery. In this case, the total dose of the therapeutic agent will be delivered when the as-manufactured inserted material is used; the inserted material will have been manufactured with demarcations to indicate fractional portions of the dose. The inserted material can be formed from Poly(DL-lactide-co-glycolide), such as Lactel, manufactured by Durect Corporation. Other suitable ways in which a therapeutic agent may be delivered to a sinus cavity will be apparent to those of ordinary skill in the art in view of the teachings herein.
IX. Exemplary Tissue Collecting Shaft Assembly
In some instances, a patient may suffer from turbinate hypertrophy (e.g., an enlarged inferior turbinate), which may adversely impact patency through the patient's paranasal cavity. It may be desirable to reduce the size of the hypertrophic turbinate through a turbinoplasty procedure in order to treat this condition. During a turbinoplasty procedure, the operator may remove bone and soft tissue of the turbinate submocosally, in order to minimize removal of the turbinate mucosa or other damage to the turbinate mucosa. Some conventional turbinoplasty procedures may include the use of instruments such as radiofrequency devices or powered microdebriders. Such instruments may require the use of additional capital equipment such as control consoles, suction components, irrigation components, etc., which may increase the cost and complexity of the instrument. Such instruments may also require connections by cable, tube, etc., which may complicate handling of the instrument.
By contrast, it should be understood that a tetherless, self-contained device similar to instrument (2600), with an auger member and a cylindraceous cutter, may also be used to remove bone and soft tissue from a turbinate in a turbinoplasty procedure. It should also be understood that a turbinoplasty procedure may require removal of more bone and/or soft tissue than would be removed in procedures such as those described above, such as where a shaft assembly (2720) is just used to form an opening (FO) through a sinus wall (SW). The bone and soft tissue that is removed in a turbinoplasty procedure may tend to accumulate on the instrument in a way that adversely impacts the efficacy of the instrument or in some other undesirable way. It may therefore be advantageous to provide for the removal of bone and soft tissue from working elements of the instrument. Moreover, it may be desirable to provide such removability of bone and soft tissue from working elements of the instrument without requiring the instrument to be removed from the patient's paranasal cavity. A merely illustrative example of a shaft assembly (3000) that may provide such operability will be described in greater detail below. Other variations and examples will be apparent to those of ordinary skill in the art in view of the teachings herein.
Cutter tube (3030) is configured to translate relative to auger member (3050) and relative to the combination of tip member (3020) and sheath tube (3010). Like cutter tube (2644) described above, cutter tube (3030) of the present example has a sharp, annular distal edge (3032). Unlike cutter tube (2644) described above, cutter tube (3030) of the present example includes a neck-down transition (3034) where the inner diameter and the outer diameter of cutter tube (3030) step down to a smaller size. In particular, the inner diameter and the outer diameter of cutter tube (3030) are reduced along the length of cutter tube (3030) that is distal to neck-down transition (3034). This reduced inner diameter of cutter tube (3030) corresponds to an effective outer diameter defined by flight (3054) of auger member (3050). Also unlike cutter tube (2644) described above, cutter tube (3030) of the present example includes a pair of fins (3040, 3042), which will be described in greater detail below. Fins (3040, 3042) are located proximal to neck-down transition (3034), in a tissue collection region (3036) of cutter tube (3030) as will also be described in greater detail below.
Auger member (3050) is configured to rotate and translate relative to cutter tube (3030) and relative to the combination of tip member (3020) and sheath tube (3010). Like auger member (2660) described above, auger member (3050) of this example comprises a minor shaft (3056) and a major shaft (3058). Minor shaft (3056) has a sharp distal tip (3052) and a helical blade or flight (3054) projecting outwardly from minor shaft (3056). Minor shaft (3056) is substantially longer than minor shaft (2666) described above, such that major shaft (3058) is located substantially further from tip (3052) of auger member (3050) than the corresponding major shaft is from tip (2662) of auger member (2660). The additional length of minor shaft (3056) corresponds with tissue collection region (3036) of cutter tube (3030).
As shown in
As shown, each fin (3040, 3042) terminates before reaching the outer diameter of minor shaft (3056), such that the terminal edge of each fin (3040, 3042) is spaced at a gap distance (d) from the outer diameter of minor shaft (3056). Various suitable values that may be used for gap distance (d) will be apparent to those of ordinary skill in the art in view of the teachings herein. In some versions, the innermost edges of fins (3040, 3042) contact the outer diameter of minor shaft (3056), such that the gap distance (d) is zero. As best seen in
In some versions, fins (3040, 3042) are formed of a rigid material, yet fins (3040, 3042) are configured to deflect relative to cutter tube (3030), such as through a hinged coupling or otherwise deformable coupling. In some other versions, fins (3040, 3042) are formed of a semi-rigid material. In still other versions, fins (3040, 3042) are formed of a flexible material (e.g., rubber, silicone, etc.). In some such versions, fins (3040, 3042) may be configured to flex along paths that are parallel to the longitudinal axis of shaft assembly (3000); yet fins (3000, 3042) may be relatively non-flexible along angular paths about the longitudinal axis of shaft assembly (3000). Other suitable properties that may be incorporated into fins (3040, 3042) will be apparent to those of ordinary skill in the art in view of the teachings herein. Similarly, other suitable relationships between fins (3040, 3042) and cutter tube (3030) will be apparent to those of ordinary skill in the art in view of the teachings herein.
While two fins (3040, 3042) are shown in the present example, any other suitable number of fins (3040, 3042) may be provided. For instance, cutter tube (3030) may have just one fin (3040 or 3042), three or more fins (3040, 3042), etc. In addition, while fins (3040, 3042) are located at different longitudinal positions along the length of shaft assembly (3000) in the present example, fins (3040, 3042) may instead be located at the same longitudinal position along the length of shaft assembly (3000). While fins (3040, 3042) are shown as being angularly offset from each other by approximately 180°, any other suitable angular offset may be used. It should therefore be understood that cutter tube (3030) may include any suitable number of fins (3040, 3042) at any suitable longitudinal position(s) and at any suitable angular position(s).
As noted above, shaft assembly (3000) may be used to remove soft tissue and bone from a turbinate (e.g., inferior turbinate) in a patient's paranasal cavity. It should be understood that this may be accomplished using a procedure like the one shown in
In order to remove the trapped tissue from auger member (3050), the operator may retract auger member (3050) proximally within shaft assembly (3000). In the present example, auger member (3050) is not rotated during this proximal retraction. As shown in
After reaching the fully proximal position shown in
It should be understood from the foregoing that shaft assembly (3000) may be operated in two modes—a tissue removal mode in a sequence similar to that shown in
While shaft assembly (3000) is described above as being used in a turbinoplasty procedure, it should be understood that shaft assembly (3000) may also be used in other kinds of procedures within a patient. Other suitable procedures in which shaft assembly (3000) may be used will be apparent to those of ordinary skill in the art in view of the teachings herein.
X. Miscellaneous
It should be understood that any of the examples described herein may include various other features in addition to or in lieu of those described above. By way of example only, any of the examples described herein may also include one or more of the various features disclosed in any of the various references that are incorporated by reference herein.
It should be understood that any one or more of the teachings, expressions, embodiments, examples, etc. described herein may be combined with any one or more of the other teachings, expressions, embodiments, examples, etc. that are described herein. The above-described teachings, expressions, embodiments, examples, etc, should therefore not be viewed in isolation relative to each other. Various suitable ways in which the teachings herein may be combined will be readily apparent to those of ordinary skill in the art in view of the teachings herein. Such modifications and variations are intended to be included within the scope of the claims.
It should be appreciated that any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated material does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
Versions described above may be designed to be disposed of after a single use, or they can be designed to be used multiple times. Versions may, in either or both cases, be reconditioned for reuse after at least one use. Reconditioning may include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, some versions of the device may be disassembled, and any number of the particular pieces or parts of the device may be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, some versions of the device may be reassembled for subsequent use either at a reconditioning facility, or by a user immediately prior to a procedure. Those skilled in the art will appreciate that reconditioning of a device may utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.
By way of example only, versions described herein may be sterilized before and/or after a procedure. In one sterilization technique, the device is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and device may then be placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation may kill bacteria on the device and in the container. The sterilized device may then be stored in the sterile container for later use. A device may also be sterilized using any other technique known in the art, including but not limited to beta or gamma radiation, ethylene oxide, or steam.
Having shown and described various embodiments of the present invention, further adaptations of the methods and systems described herein may be accomplished by appropriate modifications by one of ordinary skill in the art without departing from the scope of the present invention. Several of such potential modifications have been mentioned, and others will be apparent to those skilled in the art. For instance, the examples, embodiments, geometrics, materials, dimensions, ratios, steps, and the like discussed above are illustrative and are not required. Accordingly, the scope of the present invention should be considered in terms of the following claims and is understood not to be limited to the details of structure and operation shown and described in the specification and drawings.
This application is a continuation of U.S. patent application Ser. No. 14/197,436, filed Mar. 5, 2014, entitled “Apparatus and Method for Treatment of Ethmoid Sinusitis,” now U.S. Pat. No. 9,629,684, issued on Apr. 25, 2017, which is a continuation-in-part of U.S. patent application Ser. No. 14/038,867, filed Sep. 27, 2013, entitled “Apparatus and Method for Treatment of Ethmoid Sinusitis,” published as U.S. Patent Pub. No. 2014/0277039 on Sep. 18, 2014, the disclosure of which is incorporated by reference herein, and which is a continuation-in-part of U.S. patent application Ser. No. 13/837,104, filed Mar. 15, 2013, entitled “Apparatus and Method for Treatment of Ethmoid Sinusitis,” now U.S. Pat. No. 9,433,437, issued on Sep. 6, 2016, the disclosure of which is incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
446173 | Hancock | Feb 1891 | A |
504424 | De Pezzer | Sep 1893 | A |
513667 | Buckingham | Jan 1894 | A |
705346 | Hamilton | Jul 1902 | A |
798775 | Forsyth | Sep 1905 | A |
816792 | Green et al. | Apr 1906 | A |
1080934 | Shackleford | Dec 1913 | A |
1200267 | Sunnergren | Oct 1916 | A |
1650959 | Pitman | Nov 1927 | A |
1735519 | Vance | Nov 1929 | A |
1828986 | Stevens | Oct 1931 | A |
1878671 | Cantor | Sep 1932 | A |
2201749 | Vandegrift | May 1940 | A |
2525183 | Robinson | Mar 1947 | A |
2493326 | Trinder | Jan 1950 | A |
2526662 | Hipps | Oct 1950 | A |
2847997 | Tibone | Aug 1958 | A |
2899227 | Gschwend | Aug 1959 | A |
2906179 | Bower | Sep 1959 | A |
2995832 | Alderson | Aug 1961 | A |
3009265 | Bexark | Nov 1961 | A |
3037286 | Bower | Jun 1962 | A |
3076637 | Moziek et al. | Feb 1963 | A |
3173418 | baran | Mar 1965 | A |
3347061 | Stuemky | Oct 1967 | A |
3376659 | Asin et al. | Apr 1968 | A |
3384970 | Avalear | May 1968 | A |
3393073 | Reutenauer et al. | Jul 1968 | A |
3435826 | Fogarty | Apr 1969 | A |
3469578 | Bierman | Sep 1969 | A |
3481043 | Esch | Dec 1969 | A |
3486539 | Jacuzzi | Dec 1969 | A |
3506005 | Gilio et al. | Apr 1970 | A |
3509638 | Macleod | May 1970 | A |
3515888 | Lewis | Jun 1970 | A |
3527220 | Summers | Sep 1970 | A |
3531868 | Stevenson | Oct 1970 | A |
3552384 | Pierie et al. | Jan 1971 | A |
3624661 | Shebanow et al. | Nov 1971 | A |
3731963 | Pond | May 1973 | A |
3792391 | Ewing | Feb 1974 | A |
3800788 | White | Apr 1974 | A |
3802096 | Matern | Apr 1974 | A |
3804081 | Kinoshita | Apr 1974 | A |
3834394 | Hunter et al. | Sep 1974 | A |
3850176 | Gottschalk | Nov 1974 | A |
3856000 | Chikama | Dec 1974 | A |
3859993 | Bitner | Jan 1975 | A |
3871365 | Chikama | Mar 1975 | A |
3894538 | Richter | Jul 1975 | A |
3903893 | Scheer | Sep 1975 | A |
3910617 | Scalza et al. | Oct 1975 | A |
3921636 | Zaffaroni | Nov 1975 | A |
3948254 | Zaffaroni | Apr 1976 | A |
3948262 | Zaffaroni | Apr 1976 | A |
3967618 | Zaffaroni | Jul 1976 | A |
3968846 | Brenner | Jul 1976 | A |
3976077 | Kerfoot | Aug 1976 | A |
3993069 | Buckles et al. | Nov 1976 | A |
3993072 | Zaffaroni | Nov 1976 | A |
3993073 | Zaffaroni | Nov 1976 | A |
4016251 | Higuchi et al. | Apr 1977 | A |
4052505 | Higuchi et al. | Oct 1977 | A |
4053975 | Olbrich et al. | Oct 1977 | A |
4069307 | Higuchi et al. | Jan 1978 | A |
4102342 | Akiyama et al. | Jul 1978 | A |
4111208 | Leuenberger | Sep 1978 | A |
4138151 | Nakao | Feb 1979 | A |
4177797 | Baylis et al. | Dec 1979 | A |
4184497 | Kolff et al. | Jan 1980 | A |
4191191 | Auburn | Mar 1980 | A |
4198766 | Camin et al. | Apr 1980 | A |
4207890 | Mamajek et al. | Jun 1980 | A |
4209919 | Kirikae et al. | Jul 1980 | A |
4213095 | Falconer | Jul 1980 | A |
4217898 | Theeuwes | Aug 1980 | A |
4248248 | De Busscher | Feb 1981 | A |
4268115 | Slemon et al. | May 1981 | A |
4299226 | Banka | Nov 1981 | A |
4299227 | Lincoff | Nov 1981 | A |
4312353 | Shahbabian | Jan 1982 | A |
4332322 | Jaeschke et al. | Jun 1982 | A |
4338941 | Payton | Jul 1982 | A |
D269204 | Trepp | May 1983 | S |
4388941 | Reidhammer | Jun 1983 | A |
RE31351 | Falconer | Aug 1983 | E |
4435716 | Zandbergen | Mar 1984 | A |
4437856 | Valli | Mar 1984 | A |
4450150 | Sidman | May 1984 | A |
4459977 | Pizon et al. | Jul 1984 | A |
4464175 | Altman et al. | Aug 1984 | A |
4471779 | Antoshkiw et al. | Sep 1984 | A |
4499899 | Lyons, III | Feb 1985 | A |
4554929 | Samson et al. | Nov 1985 | A |
4564364 | Zaffaroni et al. | Jan 1986 | A |
4571239 | Heyman | Feb 1986 | A |
4571240 | Samson et al. | Feb 1986 | A |
4581017 | Sahota | Apr 1986 | A |
4585000 | Hershenson | Apr 1986 | A |
D283921 | Dyak | May 1986 | S |
4589868 | Dretler | May 1986 | A |
4596528 | Lewis et al. | Jun 1986 | A |
D284892 | Glassman | Jul 1986 | S |
4603564 | Kleinhany et al. | Aug 1986 | A |
4606346 | Berg et al. | Aug 1986 | A |
4607622 | Fritch et al. | Aug 1986 | A |
4637389 | Heyden | Jan 1987 | A |
4639244 | Rizk et al. | Jan 1987 | A |
4645495 | Vaillancourt | Feb 1987 | A |
4669469 | Gifford, III | Jun 1987 | A |
4672961 | Davies | Jun 1987 | A |
4675613 | Naegeli et al. | Jun 1987 | A |
4691948 | Austin, Jr. et al. | Sep 1987 | A |
4708434 | Tsuno | Nov 1987 | A |
4708834 | Cohen et al. | Nov 1987 | A |
4726772 | Amplatz | Feb 1988 | A |
4736970 | McGourty et al. | Apr 1988 | A |
4737141 | Spits | Apr 1988 | A |
4748869 | Ohtsuka | Jun 1988 | A |
4748969 | Wardle | Jun 1988 | A |
4748986 | Morrison et al. | Jun 1988 | A |
4755171 | Tennant | Jul 1988 | A |
4771776 | Powell et al. | Sep 1988 | A |
4793359 | Sharrow | Dec 1988 | A |
4795439 | Guest | Jan 1989 | A |
4796629 | Grayzel | Jan 1989 | A |
4803076 | Ranade | Feb 1989 | A |
4807710 | Greeley | Feb 1989 | A |
4811743 | Stevens | Mar 1989 | A |
4815478 | Buchbinder et al. | Mar 1989 | A |
4819619 | Augustine et al. | Apr 1989 | A |
4846186 | Box et al. | Jul 1989 | A |
4847258 | Sturm et al. | Jul 1989 | A |
4851228 | Zenter et al. | Jul 1989 | A |
4854330 | Evans, III et al. | Aug 1989 | A |
4862874 | Kellner | Sep 1989 | A |
4867138 | Kubota et al. | Sep 1989 | A |
4883465 | Brennan | Nov 1989 | A |
4897651 | DeMonte | Jan 1990 | A |
4898577 | Badger et al. | Feb 1990 | A |
4917419 | Mora, Jr. et al. | Apr 1990 | A |
4917667 | Jackson | Apr 1990 | A |
4919112 | Siegmund | Apr 1990 | A |
4920967 | Cottonaro et al. | May 1990 | A |
4925445 | Sakamoto et al. | May 1990 | A |
4940062 | Hampton et al. | Jul 1990 | A |
4943275 | Stricker | Jul 1990 | A |
4946466 | Pinchuk et al. | Aug 1990 | A |
4961433 | Christian | Oct 1990 | A |
4966163 | Kraus et al. | Oct 1990 | A |
4984581 | Stice | Jan 1991 | A |
4994033 | Shockey et al. | Feb 1991 | A |
4998916 | Hammerslag et al. | Mar 1991 | A |
4998917 | Gaiser et al. | Mar 1991 | A |
5001825 | Halpern | Mar 1991 | A |
5002322 | Fukumoto | Mar 1991 | A |
5019075 | Spears et al. | May 1991 | A |
5019372 | Folkman et al. | May 1991 | A |
5020514 | Heckele | Jun 1991 | A |
5021043 | Becker et al. | Jun 1991 | A |
5024650 | Hagiwara et al. | Jun 1991 | A |
5024658 | Kozlov et al. | Jun 1991 | A |
5026384 | Farr et al. | Jun 1991 | A |
5030227 | Rosenbluth et al. | Jul 1991 | A |
5041089 | Mueller et al. | Aug 1991 | A |
5044678 | Detweiler | Sep 1991 | A |
5047040 | Simpson et al. | Sep 1991 | A |
5053007 | Euteneuer | Oct 1991 | A |
5055051 | Duncan | Oct 1991 | A |
5060660 | Gambale et al. | Oct 1991 | A |
5067489 | lind | Nov 1991 | A |
5069226 | Yamauchi et al. | Dec 1991 | A |
5087244 | Wolinsky et al. | Feb 1992 | A |
5087246 | Smith | Feb 1992 | A |
5090595 | Vandeninck | Feb 1992 | A |
5090910 | Narlo | Feb 1992 | A |
5112228 | Zouras | May 1992 | A |
5116311 | Lofstedt | May 1992 | A |
5127393 | McFarlin et al. | Jul 1992 | A |
5137517 | Loney et al. | Aug 1992 | A |
5139510 | Goldsmith, III et al. | Aug 1992 | A |
5139832 | Hayashi et al. | Aug 1992 | A |
D329496 | Wotton | Sep 1992 | S |
5152747 | Oliver | Oct 1992 | A |
5156595 | Adams | Oct 1992 | A |
5163989 | Campbell et al. | Nov 1992 | A |
5167220 | Brown | Dec 1992 | A |
5168864 | Shockey | Dec 1992 | A |
5169043 | Catania | Dec 1992 | A |
5169386 | Becker et al. | Dec 1992 | A |
5171233 | Amplatz et al. | Dec 1992 | A |
5180368 | Garrison | Jan 1993 | A |
5183470 | Wttermann | Feb 1993 | A |
5189110 | Ikematu et al. | Feb 1993 | A |
5195168 | Yong | Mar 1993 | A |
5197457 | Adair | Mar 1993 | A |
5207695 | Trout, III | May 1993 | A |
5211952 | Spicer et al. | May 1993 | A |
5215105 | Kizelshteyn et al. | Jun 1993 | A |
5221260 | Burns et al. | Jun 1993 | A |
5226302 | Anderson | Jul 1993 | A |
5230348 | Ishibe et al. | Jul 1993 | A |
5236422 | Eplett, Jr. | Aug 1993 | A |
5243996 | Hall | Sep 1993 | A |
D340111 | Yoshikawa | Oct 1993 | S |
5250059 | Andreas et al. | Oct 1993 | A |
5251092 | Brady et al. | Oct 1993 | A |
5252183 | Shaban et al. | Oct 1993 | A |
5255679 | Imran | Oct 1993 | A |
5256144 | Kraus et al. | Oct 1993 | A |
5258003 | Ciaglia et al. | Nov 1993 | A |
5263926 | Wilk | Nov 1993 | A |
5264260 | Saab | Nov 1993 | A |
5267965 | Deniega | Dec 1993 | A |
5270086 | Hamlin | Dec 1993 | A |
5273052 | Kraus et al. | Dec 1993 | A |
5275593 | Easley et al. | Jan 1994 | A |
5286254 | Shapland et al. | Feb 1994 | A |
5290310 | Makower et al. | Mar 1994 | A |
5295694 | Levin | Mar 1994 | A |
5300085 | Yock | Apr 1994 | A |
5304123 | Atala et al. | Apr 1994 | A |
5308326 | Zimmon | May 1994 | A |
5313967 | Lieber et al. | May 1994 | A |
5314417 | Stephens et al. | May 1994 | A |
5315618 | Yoshida | May 1994 | A |
5324306 | Makower et al. | Jun 1994 | A |
5333620 | Moutafis et al. | Aug 1994 | A |
5334167 | Cocanower | Aug 1994 | A |
5336163 | DeMane et al. | Aug 1994 | A |
5341818 | Abrams et al. | Aug 1994 | A |
5342296 | Persson et al. | Aug 1994 | A |
5343865 | Gardineer et al. | Sep 1994 | A |
5345945 | Hodgson et al. | Sep 1994 | A |
5346075 | Nichols et al. | Sep 1994 | A |
5346508 | Hastings | Sep 1994 | A |
5348537 | Wiesner et al. | Sep 1994 | A |
5350396 | Eliachar | Sep 1994 | A |
5353804 | Kornberg et al. | Oct 1994 | A |
5356418 | Shturman | Oct 1994 | A |
5368049 | Raman et al. | Nov 1994 | A |
5368558 | Nita | Nov 1994 | A |
5368566 | Crocker | Nov 1994 | A |
5372138 | Crowley et al. | Dec 1994 | A |
5372584 | Zink et al. | Dec 1994 | A |
D355031 | Yoshikawa | Jan 1995 | S |
5386817 | Jones | Feb 1995 | A |
5391147 | Imran et al. | Feb 1995 | A |
5391179 | Mezzoli | Feb 1995 | A |
5402799 | Colon et al. | Apr 1995 | A |
5403338 | Milo | Apr 1995 | A |
5409444 | Kensey | Apr 1995 | A |
5411475 | Atala et al. | May 1995 | A |
5411476 | Abrams et al. | May 1995 | A |
5411477 | Saab | May 1995 | A |
5415633 | Lazarus | May 1995 | A |
5425370 | Vilkomerson | Jun 1995 | A |
5439446 | Barry | Aug 1995 | A |
5441494 | Ortiz | Aug 1995 | A |
5441497 | Narciso, Jr. | Aug 1995 | A |
5450853 | Hastings et al. | Sep 1995 | A |
5451221 | Cho et al. | Sep 1995 | A |
5454817 | Katz | Oct 1995 | A |
5458572 | Campbell et al. | Oct 1995 | A |
5465717 | Imran et al. | Nov 1995 | A |
5465733 | Hinohara et al. | Nov 1995 | A |
5478565 | Geria | Dec 1995 | A |
5486181 | Cohen et al. | Jan 1996 | A |
5496338 | Miyagi et al. | Mar 1996 | A |
5497783 | Urick et al. | Mar 1996 | A |
5507301 | Wasicek et al. | Apr 1996 | A |
5507725 | Savage et al. | Apr 1996 | A |
5507766 | Kugo et al. | Apr 1996 | A |
5512055 | Domb et al. | Apr 1996 | A |
5514128 | Hillsman et al. | May 1996 | A |
5519532 | Broome | May 1996 | A |
5531676 | Edwards et al. | Jul 1996 | A |
5533985 | Wang | Jul 1996 | A |
5538008 | Crowe | Jul 1996 | A |
5546964 | Stangerup | Aug 1996 | A |
5549542 | Kovalcheck | Aug 1996 | A |
5558073 | Pomeranz et al. | Sep 1996 | A |
5558652 | Henke | Sep 1996 | A |
5562619 | Mirarchi et al. | Oct 1996 | A |
5568809 | Ben-Haim | Oct 1996 | A |
5571086 | Kaplan et al. | Nov 1996 | A |
5575804 | Yoon | Nov 1996 | A |
5578007 | Imran | Nov 1996 | A |
5578048 | Pasqualucci et al. | Nov 1996 | A |
5584827 | Korteweg et al. | Dec 1996 | A |
5591194 | Berthiaume | Jan 1997 | A |
5599284 | Shea | Feb 1997 | A |
5599304 | Shaari | Feb 1997 | A |
5599576 | Opolski | Feb 1997 | A |
5601087 | Gunderson et al. | Feb 1997 | A |
5601594 | Best | Feb 1997 | A |
5607386 | Flam | Mar 1997 | A |
5615839 | Hartwig | Apr 1997 | A |
5617870 | Hastings et al. | Apr 1997 | A |
5626374 | Kim | May 1997 | A |
5633000 | Grossman et al. | May 1997 | A |
5634908 | Loomas | Jun 1997 | A |
5638819 | Manwaring et al. | Jun 1997 | A |
5643251 | Hillsman et al. | Jul 1997 | A |
5645789 | Roucher, Jr. | Jul 1997 | A |
5647361 | Damadian | Jul 1997 | A |
5656030 | Hunjan et al. | Aug 1997 | A |
5662674 | Debbas | Sep 1997 | A |
5664567 | Linder | Sep 1997 | A |
5664580 | Erickson et al. | Sep 1997 | A |
5665052 | Bullard | Sep 1997 | A |
5669388 | Vilkomerson | Sep 1997 | A |
5673707 | Chandrasekaran | Oct 1997 | A |
5676673 | Ferre et al. | Oct 1997 | A |
5679400 | Tuch | Oct 1997 | A |
5682199 | Lankford | Oct 1997 | A |
5685838 | Peters et al. | Nov 1997 | A |
5685847 | Barry | Nov 1997 | A |
5690373 | Luker | Nov 1997 | A |
5693065 | Rains, III | Dec 1997 | A |
5694945 | Ben-Haim | Dec 1997 | A |
5697159 | Linden | Dec 1997 | A |
5700286 | Tartaglia et al. | Dec 1997 | A |
5707389 | Louw et al. | Jan 1998 | A |
5708175 | Loyanagi et al. | Jan 1998 | A |
5711315 | Jerusalmy | Jan 1998 | A |
5713839 | Shea | Feb 1998 | A |
5713946 | Ben-Haim | Feb 1998 | A |
5718702 | Edwards | Feb 1998 | A |
5720300 | Fagan et al. | Feb 1998 | A |
5722401 | Pietroski et al. | Mar 1998 | A |
5722984 | Fischell et al. | Mar 1998 | A |
5729129 | Acker | Mar 1998 | A |
5730128 | Pomeranz et al. | Mar 1998 | A |
5733248 | Adams et al. | Mar 1998 | A |
5752513 | Acker et al. | May 1998 | A |
5762604 | Kieturakis | Jun 1998 | A |
5766158 | Opolski | Jun 1998 | A |
5775327 | Randolph et al. | Jul 1998 | A |
5776158 | Chou | Jul 1998 | A |
5779699 | Lipson | Jul 1998 | A |
5789391 | Jacobus et al. | Aug 1998 | A |
5792100 | Shantha | Aug 1998 | A |
5797878 | Bleam | Aug 1998 | A |
5803089 | Ferre et al. | Sep 1998 | A |
5814016 | Valley et al. | Sep 1998 | A |
5819723 | Joseph | Oct 1998 | A |
5820568 | Willis | Oct 1998 | A |
5824044 | Quiachon et al. | Oct 1998 | A |
5824048 | Tuch | Oct 1998 | A |
5824173 | Fontirroche et al. | Oct 1998 | A |
5827224 | Shippert | Oct 1998 | A |
5830188 | Abouleish | Nov 1998 | A |
5833608 | Acker | Nov 1998 | A |
5833645 | Lieber et al. | Nov 1998 | A |
5833650 | Imran | Nov 1998 | A |
5833682 | Amplatz et al. | Nov 1998 | A |
5836638 | Slocum | Nov 1998 | A |
5836935 | Ashton et al. | Nov 1998 | A |
5837313 | Ding et al. | Nov 1998 | A |
5843089 | Sahatjian et al. | Dec 1998 | A |
5843113 | High | Dec 1998 | A |
5846259 | Berthiaume | Dec 1998 | A |
5857998 | Barry | Jan 1999 | A |
5862693 | Myers et al. | Jan 1999 | A |
5865767 | Frechette et al. | Feb 1999 | A |
5872879 | Hamm | Feb 1999 | A |
5873835 | Hastings | Feb 1999 | A |
5887467 | Butterweck et al. | Mar 1999 | A |
5902247 | Coe et al. | May 1999 | A |
5902333 | Roberts et al. | May 1999 | A |
5904701 | Daneshvar | May 1999 | A |
5908407 | Frazee et al. | Jun 1999 | A |
5916193 | Stevens et al. | Jun 1999 | A |
5928192 | Maahs | Jul 1999 | A |
5931811 | Haissaguerre et al. | Aug 1999 | A |
5931818 | Werp et al. | Aug 1999 | A |
5932035 | Koger et al. | Aug 1999 | A |
5935061 | Acker et al. | Aug 1999 | A |
5941816 | Barthel et al. | Aug 1999 | A |
D413629 | Wolff et al. | Sep 1999 | S |
5947988 | Smith | Sep 1999 | A |
5949929 | Hamm | Sep 1999 | A |
5954693 | Barry | Sep 1999 | A |
5954694 | Sunseri | Sep 1999 | A |
5957842 | Littmann et al. | Sep 1999 | A |
5968085 | Morris et al. | Oct 1999 | A |
5971975 | Mills et al. | Oct 1999 | A |
5979290 | Simeone | Nov 1999 | A |
5980503 | Chin | Nov 1999 | A |
5980551 | Summers et al. | Nov 1999 | A |
5984945 | Sirhan | Nov 1999 | A |
5985307 | Hanson et al. | Nov 1999 | A |
5997562 | Zadno-Azizi | Dec 1999 | A |
6006126 | Cosman | Dec 1999 | A |
6006130 | Higo et al. | Dec 1999 | A |
6007516 | Burbank et al. | Dec 1999 | A |
6007991 | Sivaraman et al. | Dec 1999 | A |
6010511 | Murphy | Jan 2000 | A |
6013019 | Fischell et al. | Jan 2000 | A |
6015414 | Werp et al. | Jan 2000 | A |
6016429 | Khafizov et al. | Jan 2000 | A |
6016439 | Acker | Jan 2000 | A |
6019736 | Avellanet et al. | Feb 2000 | A |
6019777 | Mackenzie | Feb 2000 | A |
6021340 | Randolph et al. | Feb 2000 | A |
6022313 | Ginn et al. | Feb 2000 | A |
6027461 | Walker et al. | Feb 2000 | A |
6027478 | Katz | Feb 2000 | A |
6030402 | Thompson et al. | Feb 2000 | A |
6039699 | Viera | Mar 2000 | A |
6042561 | Ash et al. | Mar 2000 | A |
6048299 | von Hoffmann | Apr 2000 | A |
6048358 | Barak | Apr 2000 | A |
6053172 | Hovda et al. | Apr 2000 | A |
6056702 | Lorenzo | May 2000 | A |
6059752 | Segal | May 2000 | A |
6071233 | Ishikawa et al. | Jun 2000 | A |
6079755 | Chang | Jun 2000 | A |
6080190 | Schwartz | Jun 2000 | A |
6083148 | Williams | Jul 2000 | A |
6083188 | Becker et al. | Jul 2000 | A |
6086585 | Hovda et al. | Jul 2000 | A |
6092846 | Fuss et al. | Jul 2000 | A |
6093150 | Chandler et al. | Jul 2000 | A |
6093195 | Ouchi | Jul 2000 | A |
6106538 | Shiber | Aug 2000 | A |
6109268 | Thapliyal et al. | Aug 2000 | A |
6110178 | Zech | Aug 2000 | A |
6113567 | becker | Sep 2000 | A |
6117105 | Bresnaham et al. | Sep 2000 | A |
6122541 | Cosman et al. | Sep 2000 | A |
6123697 | Shippert | Sep 2000 | A |
6136006 | Johnson et al. | Oct 2000 | A |
6139510 | Palermo | Oct 2000 | A |
6142957 | Diamond et al. | Nov 2000 | A |
6148823 | Hastings | Nov 2000 | A |
6149213 | Sokurenko et al. | Nov 2000 | A |
6159170 | Borodulin et al. | Dec 2000 | A |
6171298 | Matsuura et al. | Jan 2001 | B1 |
6171303 | Ben-Haim | Jan 2001 | B1 |
6174280 | Oneda et al. | Jan 2001 | B1 |
6176829 | Vilkomerson | Jan 2001 | B1 |
6179788 | Sullivan | Jan 2001 | B1 |
6179811 | Fugoso et al. | Jan 2001 | B1 |
6183461 | Matsuura et al. | Feb 2001 | B1 |
6183464 | Sharp et al. | Feb 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6190381 | Olsen et al. | Feb 2001 | B1 |
6193650 | Ryan, Jr. | Feb 2001 | B1 |
6195225 | Komatsu et al. | Feb 2001 | B1 |
6200257 | Winkler | Mar 2001 | B1 |
6206870 | Kanner | Mar 2001 | B1 |
6213975 | Laksin | Apr 2001 | B1 |
6221042 | Adams | Apr 2001 | B1 |
6231543 | Hegde et al. | May 2001 | B1 |
6234958 | Snoke et al. | May 2001 | B1 |
6238355 | Daum | May 2001 | B1 |
6238364 | Becker | May 2001 | B1 |
6238391 | Olsen et al. | May 2001 | B1 |
6241519 | Sedleemayer | Jun 2001 | B1 |
6249180 | Maalej et al. | Jun 2001 | B1 |
6254550 | McNamara et al. | Jul 2001 | B1 |
6268574 | Edens | Jul 2001 | B1 |
6293957 | Peters et al. | Sep 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6306105 | Rooney et al. | Oct 2001 | B1 |
6306124 | Jones et al. | Oct 2001 | B1 |
D450382 | Nestenborg | Nov 2001 | S |
6322495 | Snow et al. | Nov 2001 | B1 |
6328564 | Thurow | Dec 2001 | B1 |
6332089 | Acker et al. | Dec 2001 | B1 |
6332891 | Himes | Dec 2001 | B1 |
6340360 | Lyles et al. | Jan 2002 | B1 |
6348041 | Klint | Feb 2002 | B1 |
6352503 | Matsui et al. | Mar 2002 | B1 |
6375615 | Flaherty et al. | Apr 2002 | B1 |
6375629 | Muni et al. | Apr 2002 | B1 |
6383146 | Klint | May 2002 | B1 |
6386197 | Miller | May 2002 | B1 |
6389313 | Marchitto et al. | May 2002 | B1 |
6390993 | Cornish et al. | May 2002 | B1 |
6394093 | Lethi | May 2002 | B1 |
6398758 | Jacobsen et al. | Jun 2002 | B1 |
6409863 | Williams et al. | Jun 2002 | B1 |
6419653 | Edwards et al. | Jul 2002 | B2 |
6423012 | Kato et al. | Jul 2002 | B1 |
6425877 | Edwards | Jul 2002 | B1 |
6432986 | Levin | Aug 2002 | B2 |
6440061 | Wenner et al. | Aug 2002 | B1 |
6443947 | Marko et al. | Sep 2002 | B1 |
6445939 | Swanson et al. | Sep 2002 | B1 |
6450975 | Brennan et al. | Sep 2002 | B1 |
6450989 | Dubrul et al. | Sep 2002 | B2 |
6464650 | Jafari et al. | Oct 2002 | B2 |
6468202 | Irion et al. | Oct 2002 | B1 |
6468297 | Williams et al. | Oct 2002 | B1 |
6485475 | Chelly | Nov 2002 | B1 |
6491940 | Levin | Dec 2002 | B1 |
6494894 | Mirarchi | Dec 2002 | B2 |
6500130 | Kinsella et al. | Dec 2002 | B2 |
6500189 | Lang et al. | Dec 2002 | B1 |
6503087 | Eggert et al. | Jan 2003 | B1 |
6503185 | Waksman et al. | Jan 2003 | B1 |
6503263 | Adams | Jan 2003 | B2 |
6511418 | Shahidi et al. | Jan 2003 | B2 |
6514249 | Maguire et al. | Feb 2003 | B1 |
6517478 | Khadem | Feb 2003 | B2 |
6524299 | Tran et al. | Feb 2003 | B1 |
6526302 | Hassett | Feb 2003 | B2 |
6527753 | Sekine et al. | Mar 2003 | B2 |
6529756 | Phan et al. | Mar 2003 | B1 |
6533754 | Hisamatsu et al. | Mar 2003 | B1 |
6536437 | Dragisic | Mar 2003 | B1 |
6537294 | Boyle et al. | Mar 2003 | B1 |
6543452 | Lavigne | Apr 2003 | B1 |
6544230 | Flaherty et al. | Apr 2003 | B1 |
6549800 | Atalar et al. | Apr 2003 | B1 |
6551239 | Renner et al. | Apr 2003 | B2 |
6569146 | Werner et al. | May 2003 | B1 |
6569147 | Evans et al. | May 2003 | B1 |
6571131 | Nguyen | May 2003 | B1 |
6572538 | Takase | Jun 2003 | B2 |
6572590 | Stevens et al. | Jun 2003 | B1 |
6579285 | Sinofsky | Jun 2003 | B2 |
6585639 | Kotmel et al. | Jul 2003 | B1 |
6585717 | Wittenberger et al. | Jul 2003 | B1 |
6585794 | Shimoda et al. | Jul 2003 | B2 |
6589237 | Woloszko et al. | Jul 2003 | B2 |
6591130 | Shahidi | Jul 2003 | B2 |
6596009 | Jelic | Jul 2003 | B1 |
6607546 | Murken | Aug 2003 | B1 |
6612999 | Brennan et al. | Sep 2003 | B2 |
6613066 | Fukaya et al. | Sep 2003 | B1 |
6616601 | Hayakawa | Sep 2003 | B2 |
6616659 | de la Torre et al. | Sep 2003 | B1 |
6616678 | Nishtala et al. | Sep 2003 | B2 |
6616913 | Mautone | Sep 2003 | B1 |
6619085 | Hsieh | Sep 2003 | B1 |
6634684 | Spiessl | Oct 2003 | B2 |
6638233 | Corvi et al. | Oct 2003 | B2 |
6638268 | Niazi | Oct 2003 | B2 |
6638291 | Ferrera et al. | Oct 2003 | B1 |
6645193 | Mangosong | Nov 2003 | B2 |
6652472 | Jafari et al. | Nov 2003 | B2 |
6652480 | Imran et al. | Nov 2003 | B1 |
6656166 | Lurie et al. | Dec 2003 | B2 |
6663589 | Halevy | Dec 2003 | B1 |
6669689 | Lehmann et al. | Dec 2003 | B2 |
6669711 | Noda | Dec 2003 | B1 |
6672773 | Glenn et al. | Jan 2004 | B1 |
6673025 | Richardson et al. | Jan 2004 | B1 |
6679871 | Hahnen | Jan 2004 | B2 |
6685648 | Flaherty et al. | Feb 2004 | B2 |
6689096 | Loubens et al. | Feb 2004 | B1 |
6689146 | Himes | Feb 2004 | B1 |
6702735 | Kelly | Mar 2004 | B2 |
6712757 | Becker et al. | Mar 2004 | B2 |
6714809 | Lee et al. | Mar 2004 | B2 |
6716216 | Boucher et al. | Apr 2004 | B1 |
6716813 | Lim et al. | Apr 2004 | B2 |
6719749 | Schweikert et al. | Apr 2004 | B1 |
6719763 | Chung et al. | Apr 2004 | B2 |
6726701 | Gilson et al. | Apr 2004 | B2 |
6755812 | Peterson et al. | Jun 2004 | B2 |
6776772 | de Vrijer et al. | Aug 2004 | B1 |
6780168 | Jellie | Aug 2004 | B2 |
6783522 | Fischell | Aug 2004 | B2 |
6783536 | Vilsmeier et al. | Aug 2004 | B2 |
6786864 | Matsuura et al. | Sep 2004 | B2 |
6796960 | Cioanta et al. | Sep 2004 | B2 |
6811544 | Schaer | Nov 2004 | B2 |
6814743 | Chin et al. | Nov 2004 | B2 |
6817364 | Garibaldi et al. | Nov 2004 | B2 |
6817976 | Rovegno | Nov 2004 | B2 |
6827683 | Otawara | Dec 2004 | B2 |
6827701 | MacMahon et al. | Dec 2004 | B2 |
6832715 | Eungard et al. | Dec 2004 | B2 |
D501677 | Becker | Feb 2005 | S |
6851290 | Meier et al. | Feb 2005 | B1 |
6860264 | Christopher | Mar 2005 | B2 |
6860849 | Matsushita et al. | Mar 2005 | B2 |
6878106 | Herrmann | Apr 2005 | B1 |
6890329 | Carroll et al. | May 2005 | B2 |
6899672 | Chin et al. | May 2005 | B2 |
6902556 | Grimes et al. | Jun 2005 | B2 |
6913763 | Lerner | Jul 2005 | B2 |
6927478 | Paek | Aug 2005 | B2 |
6939361 | Kleshinski | Sep 2005 | B1 |
6939374 | Banik et al. | Sep 2005 | B2 |
6955657 | Webler | Oct 2005 | B1 |
6966906 | Brown | Nov 2005 | B2 |
6971998 | Rosenman et al. | Dec 2005 | B2 |
6979290 | Mourlas et al. | Dec 2005 | B2 |
6984203 | Tartaglia et al. | Jan 2006 | B2 |
6991597 | Gellman et al. | Jan 2006 | B2 |
6997931 | Sauer et al. | Feb 2006 | B2 |
6997941 | Sharkey et al. | Feb 2006 | B2 |
7004173 | Sparks et al. | Feb 2006 | B2 |
7008381 | Janssens | Mar 2006 | B2 |
7008412 | Maginot | Mar 2006 | B2 |
7011654 | Dubrul et al. | Mar 2006 | B2 |
7022105 | Edwards | Apr 2006 | B1 |
7043961 | Pandey | May 2006 | B2 |
7052474 | Castell et al. | May 2006 | B2 |
7056284 | Martone et al. | Jun 2006 | B2 |
7056303 | Dennis et al. | Jun 2006 | B2 |
7074197 | Reynolds et al. | Jul 2006 | B2 |
7074426 | Kochinke | Jul 2006 | B2 |
7097612 | Bertolero et al. | Aug 2006 | B2 |
7108677 | Courtney et al. | Sep 2006 | B2 |
7108706 | Hogle | Sep 2006 | B2 |
7125252 | Rouiller et al. | Oct 2006 | B2 |
7128718 | Hojeibane et al. | Oct 2006 | B2 |
7131969 | Hovda et al. | Nov 2006 | B1 |
7140480 | Drussel et al. | Nov 2006 | B2 |
D534216 | Makower et al. | Dec 2006 | S |
7160255 | Saadat | Jan 2007 | B2 |
7169140 | Kume | Jan 2007 | B1 |
7169163 | Becker | Jan 2007 | B2 |
7172562 | McKinley | Feb 2007 | B2 |
7174774 | Pawar et al. | Feb 2007 | B2 |
7182735 | Shireman et al. | Feb 2007 | B2 |
7184827 | Edwards | Feb 2007 | B1 |
7214201 | Burmeister et al. | May 2007 | B2 |
7233820 | Gilboa | Jun 2007 | B2 |
7235088 | Pintor et al. | Jun 2007 | B2 |
7235099 | Duncavage et al. | Jun 2007 | B1 |
7237313 | Skujins et al. | Jul 2007 | B2 |
7252677 | Burwell et al. | Aug 2007 | B2 |
7258694 | Choi et al. | Aug 2007 | B1 |
7282057 | Surti et al. | Oct 2007 | B2 |
7294345 | Haapakumpu et al. | Nov 2007 | B2 |
7294365 | Hayakawa et al. | Nov 2007 | B2 |
7313430 | Urquhart et al. | Dec 2007 | B2 |
7316168 | van der Knokke et al. | Jan 2008 | B2 |
7316656 | Shireman et al. | Jan 2008 | B2 |
7318831 | Alvarez et al. | Jan 2008 | B2 |
7322934 | Miyake et al. | Jan 2008 | B2 |
7326235 | Edwards | Feb 2008 | B2 |
7338467 | Lutter | Mar 2008 | B2 |
7343920 | Toby et al. | Mar 2008 | B2 |
7359755 | Jones et al. | Apr 2008 | B2 |
7361168 | Makower et al. | Apr 2008 | B2 |
7366562 | Dukesherer | Apr 2008 | B2 |
7371210 | Brock et al. | May 2008 | B2 |
7381205 | Thommen | Jun 2008 | B2 |
7410480 | Muni et al. | Aug 2008 | B2 |
7419497 | Muni et al. | Sep 2008 | B2 |
7438701 | Theeuwes et al. | Oct 2008 | B2 |
7442191 | Hovda et al. | Oct 2008 | B2 |
7452351 | Miller et al. | Nov 2008 | B2 |
7454244 | Kassab et al. | Nov 2008 | B2 |
7462175 | Chang et al. | Dec 2008 | B2 |
7471994 | Ford et al. | Dec 2008 | B2 |
7481218 | Djupesland | Jan 2009 | B2 |
7481800 | Jacques | Jan 2009 | B2 |
D586465 | Faulkner et al. | Feb 2009 | S |
D586916 | Faulkner et al. | Feb 2009 | S |
7485125 | Sjostrom | Feb 2009 | B2 |
7488313 | Segal et al. | Feb 2009 | B2 |
7488337 | Saab et al. | Feb 2009 | B2 |
7493156 | Manning et al. | Feb 2009 | B2 |
7500971 | Chang et al. | Mar 2009 | B2 |
D590502 | Geisser et al. | Apr 2009 | S |
7520876 | Ressemann et al. | Apr 2009 | B2 |
7532920 | Ainsworth et al. | May 2009 | B1 |
7544192 | Eaton et al. | Jun 2009 | B2 |
7559925 | Goldfarb et al. | Jul 2009 | B2 |
7569056 | Cragg et al. | Aug 2009 | B2 |
7610104 | Kaplan et al. | Oct 2009 | B2 |
7615005 | Stefanchik et al. | Nov 2009 | B2 |
7618450 | Zarowski et al. | Nov 2009 | B2 |
7625335 | Deichmann et al. | Dec 2009 | B2 |
7632291 | Stephens et al. | Dec 2009 | B2 |
7634233 | Deng et al. | Dec 2009 | B2 |
7641644 | Chang et al. | Jan 2010 | B2 |
7641668 | Perry et al. | Jan 2010 | B2 |
7645272 | Chang et al. | Jan 2010 | B2 |
7648367 | Makower et al. | Jan 2010 | B1 |
7654997 | Makower et al. | Feb 2010 | B2 |
7680244 | Gertner et al. | Mar 2010 | B2 |
7686798 | Eaton et al. | Mar 2010 | B2 |
7691120 | Shluzas et al. | Apr 2010 | B2 |
7717933 | Becker | May 2010 | B2 |
7720521 | Chang et al. | May 2010 | B2 |
7727186 | Makower et al. | Jun 2010 | B2 |
7727226 | Chang et al. | Jun 2010 | B2 |
7736301 | Webler et al. | Jun 2010 | B1 |
7740642 | Becker | Jun 2010 | B2 |
7753929 | Becker | Jul 2010 | B2 |
7753930 | Becker | Jul 2010 | B2 |
7771409 | Chang et al. | Aug 2010 | B2 |
7771482 | Karmon | Aug 2010 | B1 |
7775968 | Mathis | Aug 2010 | B2 |
7799048 | Hudson et al. | Sep 2010 | B2 |
7803150 | Chang et al. | Sep 2010 | B2 |
7806871 | Li et al. | Oct 2010 | B2 |
7833282 | Mandpe | Nov 2010 | B2 |
7837672 | Intoccia | Nov 2010 | B2 |
7840254 | Glossop | Nov 2010 | B2 |
7849938 | Maier | Dec 2010 | B1 |
7854744 | Becker | Dec 2010 | B2 |
D630321 | Hamilton, Jr. | Jan 2011 | S |
7875050 | Samson et al. | Jan 2011 | B2 |
D632791 | Murner | Feb 2011 | S |
7883717 | Varner et al. | Feb 2011 | B2 |
7896891 | Catanese, III et al. | Mar 2011 | B2 |
7905896 | Straub | Mar 2011 | B2 |
7951132 | Eaton et al. | May 2011 | B2 |
7988705 | Galdonik et al. | Aug 2011 | B2 |
7993353 | Roβner et al. | Aug 2011 | B2 |
8002740 | Willink et al. | Aug 2011 | B2 |
8014849 | Peckham | Sep 2011 | B2 |
8016752 | Armstrong et al. | Sep 2011 | B2 |
8025635 | Eaton et al. | Sep 2011 | B2 |
8080000 | Makower et al. | Dec 2011 | B2 |
8088063 | Fujikura et al. | Jan 2012 | B2 |
8088101 | Chang et al. | Jan 2012 | B2 |
8090433 | Makower et al. | Jan 2012 | B2 |
8100933 | Becker | Jan 2012 | B2 |
8104483 | Taylor | Jan 2012 | B2 |
8197552 | Mandpe | Jan 2012 | B2 |
8114062 | Muni et al. | Feb 2012 | B2 |
8114113 | Becker | Feb 2012 | B2 |
8116875 | Osypka et al. | Feb 2012 | B2 |
8123722 | Chang et al. | Feb 2012 | B2 |
8142422 | Makower et al. | Mar 2012 | B2 |
8147545 | Avior | Apr 2012 | B2 |
8167821 | Sharrow | May 2012 | B2 |
8172863 | Robinson et al. | May 2012 | B2 |
8187254 | Hissink et al. | May 2012 | B2 |
8190389 | Kim et al. | May 2012 | B2 |
8197433 | Cohen | Jun 2012 | B2 |
8239001 | Verard et al. | Aug 2012 | B2 |
8241266 | Keith et al. | Aug 2012 | B2 |
8249700 | Clifford et al. | Aug 2012 | B2 |
8277386 | Ahmed et al. | Oct 2012 | B2 |
8317816 | Becker | Nov 2012 | B2 |
8337454 | Eaton et al. | Dec 2012 | B2 |
8348969 | Keith et al. | Jan 2013 | B2 |
8388642 | Muni et al. | Mar 2013 | B2 |
8403954 | Santin et al. | Mar 2013 | B2 |
8439687 | Morriss et al. | May 2013 | B1 |
8454603 | Webb et al. | Jun 2013 | B2 |
8480696 | Clague et al. | Jul 2013 | B2 |
8535707 | Arensdorf et al. | Sep 2013 | B2 |
8585728 | Keith et al. | Nov 2013 | B2 |
8585753 | Scanlon et al. | Nov 2013 | B2 |
8608360 | Nath | Dec 2013 | B2 |
8642631 | Anderson et al. | Feb 2014 | B2 |
8647256 | Carrillo | Feb 2014 | B2 |
8882697 | Celermajer et al. | Nov 2014 | B2 |
20010001124 | Mueller | May 2001 | A1 |
20010004644 | Levin | Jun 2001 | A1 |
20010034530 | Malackowski et al. | Oct 2001 | A1 |
20020006961 | Katz et al. | Jan 2002 | A1 |
20020055746 | Burke et al. | May 2002 | A1 |
20020090388 | Humes et al. | Jul 2002 | A1 |
20020111603 | Cheikh | Aug 2002 | A1 |
20020138021 | Pflueger | Sep 2002 | A1 |
20020138091 | Pflueger | Sep 2002 | A1 |
20030013985 | Saadat | Jan 2003 | A1 |
20030017111 | Rabito | Jan 2003 | A1 |
20030018291 | Hill et al. | Jan 2003 | A1 |
20030040697 | Pass et al. | Feb 2003 | A1 |
20030078608 | Shiu | Apr 2003 | A1 |
20030083608 | Evans et al. | May 2003 | A1 |
20030114732 | Webler et al. | Jun 2003 | A1 |
20030114773 | Janssens | Jun 2003 | A1 |
20030163154 | Miyata et al. | Aug 2003 | A1 |
20040015150 | Zadno-Azizi | Jan 2004 | A1 |
20040018980 | Gurney et al. | Jan 2004 | A1 |
20040034311 | Mihalcik | Feb 2004 | A1 |
20040043052 | Hunter et al. | Mar 2004 | A1 |
20040058992 | Marinello et al. | Mar 2004 | A1 |
20040064105 | Capes et al. | Apr 2004 | A1 |
20040116958 | Gopferich et al. | Jun 2004 | A1 |
20040127820 | Clayman et al. | Jul 2004 | A1 |
20040158229 | Quinn | Aug 2004 | A1 |
20040181175 | Clayman et al. | Sep 2004 | A1 |
20040193073 | DeMello et al. | Sep 2004 | A1 |
20040230156 | Schreck et al. | Nov 2004 | A1 |
20040236231 | Knighton et al. | Nov 2004 | A1 |
20040249243 | Kleiner | Dec 2004 | A1 |
20040265082 | Abrams | Dec 2004 | A1 |
20040267347 | Cervantes | Dec 2004 | A1 |
20050027249 | Reifart et al. | Feb 2005 | A1 |
20050055077 | Marco et al. | Mar 2005 | A1 |
20050059931 | Garrison et al. | Mar 2005 | A1 |
20050089670 | Large | Apr 2005 | A1 |
20050107738 | Slater et al. | May 2005 | A1 |
20050113687 | Herweck et al. | May 2005 | A1 |
20050113850 | Tagge | May 2005 | A1 |
20050119590 | Burmeister et al. | Jun 2005 | A1 |
20050131316 | Flagle et al. | Jun 2005 | A1 |
20050143687 | Rosenblatt et al. | Jun 2005 | A1 |
20050182319 | Glossop | Aug 2005 | A1 |
20050234507 | Geske et al. | Oct 2005 | A1 |
20050244472 | Hughes et al. | Nov 2005 | A1 |
20050283221 | Mann et al. | Dec 2005 | A1 |
20060004323 | Chang et al. | Jan 2006 | A1 |
20060004368 | Zaleski et al. | Jan 2006 | A1 |
20060058837 | Bose et al. | Mar 2006 | A1 |
20060063973 | Makower et al. | Mar 2006 | A1 |
20060173382 | Schreiner | Aug 2006 | A1 |
20060190022 | Beyar et al. | Aug 2006 | A1 |
20060211752 | Kohn et al. | Sep 2006 | A1 |
20060253069 | Li et al. | Nov 2006 | A1 |
20060271024 | Gertner et al. | Nov 2006 | A1 |
20070020196 | Pipkin et al. | Jan 2007 | A1 |
20070112358 | Abbott | May 2007 | A1 |
20070129751 | Muni et al. | Jun 2007 | A1 |
20070135789 | Chang et al. | Jun 2007 | A1 |
20070167682 | Goldfarb et al. | Jul 2007 | A1 |
20070208252 | Makower | Sep 2007 | A1 |
20070208301 | Evard et al. | Sep 2007 | A1 |
20070249896 | Goldfarb et al. | Oct 2007 | A1 |
20070269385 | Yun et al. | Nov 2007 | A1 |
20070282305 | Goldfarb et al. | Dec 2007 | A1 |
20070288036 | Seshadri et al. | Dec 2007 | A1 |
20070293727 | Goldfarb et al. | Dec 2007 | A1 |
20070293946 | Gonzales et al. | Dec 2007 | A1 |
20080015540 | Muni et al. | Jan 2008 | A1 |
20080033519 | Burwell et al. | Feb 2008 | A1 |
20080051804 | Cottler et al. | Feb 2008 | A1 |
20080103521 | Makower et al. | May 2008 | A1 |
20080119693 | Makower et al. | May 2008 | A1 |
20080125626 | Chang et al. | May 2008 | A1 |
20080132938 | Chang et al. | Jun 2008 | A1 |
20080183128 | Morriss et al. | Jul 2008 | A1 |
20080188870 | Andre et al. | Aug 2008 | A1 |
20080195041 | Goldfarb et al. | Aug 2008 | A1 |
20080228085 | Jenkins et al. | Sep 2008 | A1 |
20080228231 | Raphael et al. | Sep 2008 | A1 |
20080262508 | Clifford et al. | Oct 2008 | A1 |
20080275483 | Makower et al. | Nov 2008 | A1 |
20080281156 | Makower et al. | Nov 2008 | A1 |
20080287908 | Muni et al. | Nov 2008 | A1 |
20080319424 | Muni et al. | Dec 2008 | A1 |
20090030274 | Goldfarb et al. | Jan 2009 | A1 |
20090088728 | Dollar et al. | Apr 2009 | A1 |
20090156980 | Eaton et al. | Jun 2009 | A1 |
20090163890 | Clifford et al. | Jun 2009 | A1 |
20090187089 | Say et al. | Jul 2009 | A1 |
20090187098 | Makower et al. | Jul 2009 | A1 |
20090198216 | Muni et al. | Aug 2009 | A1 |
20090240112 | Goldfarb et al. | Sep 2009 | A1 |
20090240237 | Goldfarb et al. | Sep 2009 | A1 |
20090312745 | Goldfarb et al. | Dec 2009 | A1 |
20100030031 | Goldfarb et al. | Feb 2010 | A1 |
20100087811 | Herrin et al. | Apr 2010 | A1 |
20100114066 | Makower et al. | May 2010 | A1 |
20100125253 | Olson et al. | May 2010 | A1 |
20100174308 | Chang et al. | Jul 2010 | A1 |
20100198191 | Clifford et al. | Aug 2010 | A1 |
20100198302 | Shalev | Aug 2010 | A1 |
20100274188 | Chang et al. | Oct 2010 | A1 |
20110004057 | Goldfarb et al. | Jan 2011 | A1 |
20110015612 | Arcand et al. | Jan 2011 | A1 |
20110015645 | Liu et al. | Jan 2011 | A1 |
20110046682 | Stephan et al. | Feb 2011 | A1 |
20120053567 | Schreck et al. | Mar 2012 | A1 |
20120078118 | Jenkins et al. | Mar 2012 | A1 |
20120109111 | Li | May 2012 | A1 |
20120184983 | Chang et al. | Jul 2012 | A1 |
20120316572 | Rosenblatt et al. | Dec 2012 | A1 |
20140276328 | Kesten et al. | Sep 2014 | A1 |
20140277039 | Liberatore et al. | Sep 2014 | A1 |
Number | Date | Country |
---|---|---|
668188 | Dec 1988 | CH |
2151720 | Jan 1994 | CN |
2352818 | Dec 1999 | CN |
3202878 | Aug 1983 | DE |
4032096 | Apr 1992 | DE |
4406077 | Sep 1994 | DE |
8810044 | Nov 1998 | DE |
29923582 | Dec 2000 | DE |
10104663 | Aug 2002 | DE |
10105592 | Aug 2002 | DE |
129634 | Jan 1985 | EP |
257605 | Mar 1988 | EP |
355996 | Feb 1990 | EP |
418391 | Mar 1991 | EP |
427852 | May 1991 | EP |
623582 | Nov 1994 | EP |
624349 | Nov 1994 | EP |
744400 | Nov 1996 | EP |
585757 | Jun 1997 | EP |
893426 | Jan 1999 | EP |
1042998 | Oct 2000 | EP |
1166710 | Jan 2002 | EP |
1413258 | Apr 2004 | EP |
1944053 | Jul 2008 | EP |
2859377 | Mar 2005 | FR |
2916144 | Nov 2008 | FR |
2125874 | Mar 1984 | GB |
2305174 | Apr 1997 | GB |
2318135 | Apr 1998 | GB |
53-67935 | Jun 1978 | JP |
10-24098 | Jan 1989 | JP |
3-503011 | Jul 1991 | JP |
3-504935 | Oct 1991 | JP |
4-221313 | Aug 1992 | JP |
5-211985 | Aug 1993 | JP |
6-277296 | Oct 1994 | JP |
7-327916 | Dec 1995 | JP |
8-317989 | Dec 1996 | JP |
11-507251 | Jun 1999 | JP |
2000-501634 | Feb 2000 | JP |
2001-501846 | Feb 2001 | JP |
2001-095815 | Apr 2001 | JP |
2001-526077 | Dec 2001 | JP |
2002-028166 | Jan 2002 | JP |
2002-508214 | Mar 2002 | JP |
2002-537908 | Nov 2002 | JP |
2002-538850 | Nov 2002 | JP |
2003-062080 | Mar 2003 | JP |
2003-521327 | Jul 2003 | JP |
2004-357728 | Dec 2004 | JP |
2005-532869 | Nov 2005 | JP |
2213530 | Oct 2003 | RU |
1662571 | Jul 1991 | SU |
WO 90011053 | Oct 1990 | WO |
WO 90014865 | Dec 1990 | WO |
WO 91017787 | Nov 1991 | WO |
WO 92015286 | Sep 1992 | WO |
WO 92022350 | Dec 1992 | WO |
WO 94012095 | Jun 1994 | WO |
WO 96029071 | Sep 1996 | WO |
WO 97021461 | Jun 1997 | WO |
WO 99024106 | May 1999 | WO |
WO 99030655 | Jun 1999 | WO |
WO 99032041 | Jul 1999 | WO |
WO 00009192 | Feb 2000 | WO |
WO 00023009 | Apr 2000 | WO |
WO 00051672 | Sep 2000 | WO |
WO 00053252 | Sep 2000 | WO |
WO 01045572 | Jun 2001 | WO |
WO 01054558 | Aug 2001 | WO |
WO 01056481 | Aug 2001 | WO |
WO 01070325 | Sep 2001 | WO |
WO 01074266 | Oct 2001 | WO |
WO 01097895 | Dec 2001 | WO |
WO 02047561 | Jun 2002 | WO |
WO 02062269 | Aug 2002 | WO |
WO 03049603 | Jun 2003 | WO |
WO 03063703 | Aug 2003 | WO |
WO 03105657 | Dec 2003 | WO |
WO 04006788 | Jan 2004 | WO |
WO 04018980 | Mar 2004 | WO |
WO 04026391 | Apr 2004 | WO |
WO 04082525 | Sep 2004 | WO |
WO 04082525 | Sep 2004 | WO |
WO 05018730 | Mar 2005 | WO |
WO 05077450 | Aug 2005 | WO |
WO 05089670 | Sep 2005 | WO |
WO 05117755 | Dec 2005 | WO |
WO 06034008 | Mar 2006 | WO |
WO 06078884 | Jul 2006 | WO |
WO 06107957 | Oct 2006 | WO |
WO 06116597 | Nov 2006 | WO |
WO 06118737 | Nov 2006 | WO |
WO 06135853 | Dec 2006 | WO |
WO 07062668 | Jun 2007 | WO |
WO 07111636 | Oct 2007 | WO |
WO 07124260 | Nov 2007 | WO |
WO 08036149 | Mar 2008 | WO |
WO 08045242 | Apr 2008 | WO |
WO 08051918 | May 2008 | WO |
WO 08134382 | Nov 2008 | WO |
Entry |
---|
Argon Medical. Maxxim Medical. Ad for Sniper EliteTM Hydrophilic Ni—Ti Allow Guidewire (2001). |
Aust, R., et al. ‘The Functional Size of the Human Maxillary Ostium in Vivo’ Acta. Otolaryn. (9178) vol. 78 pp. 432-435. |
Baim, D.S., MD ‘Grossman's Cardiac Catheterization, Angiography, and Intervention’(2000) Lippincott Williams & Wilkins pp. 76, 84 & 214. |
Barrett, S. ‘Be Wary of Neurocranial Restructuring (NCR)’ Chirobase; Jul. 2003; www.chirobase.org/06DD/ncr.html. |
Bartal N. ‘An Improved stent for Use in the Surgical Management of Congential Posterior Choanal Atresia’ J. Laryngol. Otol (1988) vol. 102 pp. 146-147. |
Becker, A.E. ‘Restenosis After Angioplasty’ The Lancet (1988) vol. 331, No. 8584 p. 532. |
Bellis, M. History of the Catheter-Balloon Catheter—Thomas Fogarty. www.inventors.about.com/library/inventors/blcatheter.htm?p=1. |
Benninger et al.; Adult Chronic Rhinosinusitis: Definitions, Diagnosis, Epidemiology, and Pathophysilogy Arch Otolaryngol Head and Neck Surg. vol. 129 (Sep. 2003) pp. A1-S32. |
Bent et al. ‘The Frontal Cell as a Cause of Frontal Sinus Obstruction’ American Journal of Rhinology, vol. 8, No. 4 (1994) pp. 185-191. |
Binner et al. ‘Fibre-Optic Transillunination of the Sinuses: A Comparison of the Value of Radiography and Transillumination in Antral Disease’ Clinical Otolaryngology. vol. 3 (1978) pp. 1-11. |
Brown, C.L. et al., ‘Safety and Feasibility of Balloon Catheter Dilation of Paranasal Sinus Ostia: A Preliminary Investigation’ Annals of Otology, Rhinology & Laryngology (2006) vol. 115, No. 4 pp. 293-299. |
Casiano et al. ‘Endoscopic Lothrop Procedure: The University of Miami Experience’ American Journal of Rhinology, vol. 12, No. 5 (1998) pp. 335-339. |
Casserly, I.P. et al., Chapter 7. ‘Guides and Wires in Percutaneous Coronary Intervention’ Strategic Approaches in Coronary Intervention (2006) Lippincott Williams & Wilkins pp. 91-99. |
Chien, Y.W. et al. ‘Nasal Systemic Drug Delivery’, Drugs and Pharmaceutical Sciences, vol. 39, pp. 60-63. |
Cohen et al. ‘Endoscopic Sinus Surgery: Where we are and where we're going’ Current Opinion in Otolaryngology & Head and Neck Surgery, vol. 13 (2005) pp. 32-38. |
Colla, A. et al., ‘Trihaloacetylated Enol Ethers—General Synthetic Procedure and Heterocyclic Ring Closure Reactions with Hydroxylamine’ Synthesis, (Jun. 1991) pp. 483-486. |
Costa, M.N. et al. ‘Endoscopic Study of the Intranasal Ostium in External Dacryocystorhinostomy Postoperative. Influence of Saline Solution and 5-Flurorouracil’ Clinics (2007) vol. 62, Issue1, pp. 41-46. |
Cussler, E.L. ‘Diffusion: Mass transfer in Fluid Systems’ Cambridge University Press (1996). |
Davis, G.E. et al. ‘A Complication from Neurocranial Restructuring’ Arch Otolaryngol Head Neck Surg. vol. 129 (Apr. 2003) pp. 472-474. |
Deutschmann, R. et al. ‘A Contribution to the Topical Treatment of [Maxillary] Sinusitis Preliminary Communication’ Stomat DDR 26, (1976) pp. 585-592. |
Domb, A. et al. ‘Handbook of Biodegradable Polymers’ Harwood Academic Publishers (1997). |
Doyle Nasal Splints, Jan 25, 2007; www.doylemedical.com/nasalsplints.htm. |
Draf, W. ‘Endonasal Micro-Endoscopic Frontal Sinus Surgery: the Fulda Concept’ Op Tech Otolaryngol Head Neck Surg. vol. 2 (1991) pp. 234-240. . |
Edmond, C. et al. ‘ENT Surgical Stimulator’ Nov. 1989. |
ENT Checklist; Physical Examination Performance Checklist [date of publication unknown]. |
Eremychev, V.A. ‘Needles for Puncture and Drainage of the Maxillary Sinus’ Meditsinskaya Tekhnika, No. 5 (1974) pp. 54.55. |
Feldman, R.L. et al., ‘New Steerable, Catheter: Ultra-Low-Profile, Fixed Wire Angioplasty Catheter: Initial Experience with the Cordis OrionTM Steerable PTCA Balloon Catheter’ Cathet. Cardiovasc. Diagn. (1990) vol. 19, No. 2, pp. 142-145. |
Ford, C.N. ‘A Multipurpose Laryngeal Injector Device’ Otolaryngol. Head Neck Surg. (1990) vol. 103, No. 1 pp. 135-137. |
Friedman, M., M.D., et al. ‘Frontal Sinus Surgery: Endoscopic Technique’ Operative Techniques in Otolarynology—Head and Neck Surgery. vol. 12, No. 2 (Jun. 2001) pp. 60-65. |
Friedman, et al. ‘Intraoperative and Postoperative Assessment of Frontal Sinus Patency by Transillumination’ Laryngoscope. vol. 110 (Apr. 2000) pp. 683-684. |
Friedman, et al ‘Middle Turbinate Medialization and Preservation in Endoscopic Surgery’ Otolaryngology—Head and Neck Surgery. (2000) vol. 123, No. 1, part 1, pp. 76-80. |
Fung, M.K.T. ‘Template for Frontal Osteoplastic Flap’ Laryngoscope. vol. 96 (1986) pp. 578-579. |
Gatot, A. et al. ‘Early treatment of Orbital Floor Fractures with Catheter Balloon in Children’ Int J. Pediatric Otorhinolaryngol (1991) vol. 21 pp. 97-101. |
Gerus, I.I. et al. ‘β-Ethoxyvinyl Polyfluroroalkyl Ketones—Versatile Synthones in Fluoroorganic Chemistry’ Journal of Fluorine Chemistry. vol. 69 (1994) pp. 195-198. Elesvier Science S.A. |
Good, R.H. ‘An Intranasal Method for Opening the Frontal Sinus Establishing the Largest Possible Drainage’ Laryngoscope. vol. 18 (1980) pp. 266-274. |
Gopferich ‘Polymer Degradation and Erosion: Mechanisms and Application’ Eur. J. Parm. Biophar. vol. 42 (1996) pp. 1-11. |
Gorlov, D.V. et al ‘Acylation and 2-Methoxypropene with Anhydrides and Halides of Perflurocarboxylic Acids in the Presence of Teriary Amines’ Russian Chemical Bulletin. vol. 48 No. 9 (Sep. 1999) pp. 1791-1792. Kluwer Academic/Plenum Publishers. |
Gottmann, et al. ‘Balloon Dilatation in the Nasal Cavity and Paranasal Sinuses’ CIRSE. (Sep. 25, 2004) pp. 1-27. |
Gottmann, et al. ‘Balloon Dilatation of Recurrent Ostial Occlusion of the Frontal Sinus’ CIRSE. (Mar. 2001). |
Gottmann, et al. ‘Successful treatment of Recurrent Post-Operative Frontal Sinus Stenoses by Balloon Dilatation’ CIRSE. (Oct. 5, 2002). |
Gupta, D. et al., ‘Dacrystitis Secondary to an Iatrogenic Foreign Body in the Lacrimal Apparatus’ Ear, Nose & Throat Journal (2009) www.findarticles.com/p/articles/mi_m0BUM/is_7_88/ai_n32428620/. |
Hashim, et al. ‘Balloon Compression of the Intermaxillary Sinus for Intractable Post Traumatic Bleeding from the Maxillary Artery’ Scandinavia Journal of Plastic and reconsruction Sergery and Hand Surgery (1999) vol. 33 pp. 321-324. |
Hojo, M. et al, ‘Electrophilic Substiutions of Olefinic Hydrogens II. Acylation of Vinyle Ethers and N Vinyl Amides Chemistry Letters’ (1976) pp. 499-502. Chemical Society of Japan. |
Hopf, J.U.G. et al. ‘Minature Endoscopes in Otorhinolaryngologic Applications’ Min Invas Ther & Allied Technol. (1998) vol. 7, No. 3, pp. 209-218. |
Hosemann, W. et al. A Dissection Course on Endoscopic Endonasal Sinus Surgery (2005) Endo-Press, Tuttlingen pp. 4-37. |
Hosemann, W. et al. ‘Endonasal Frontal Sinusotomy in Surgical Management of Chronic Sinusitis: A Critical Evaluation’ American Journal of Rhinology. vol. 11, No. 1 (1997) pp. 1-9. |
Hosemann, M.E. et al. ‘Experimental investigations on wound healing of the paranasal sinuses. II. Spontaneous wound closure and pharmacological effects in standardized animal model.’ HNO 39 (1991) pp. 48-54. |
Hosemann, W.G. et al. ‘Minimally Invasive Endonasal Sinus Surgery’ Thieme, Stuttgart, New York (2000). |
Hosemann, M.E. et al. ‘Normal Wound Healing of the Paranasal Sinuses—Clinical and Experimental Investigations’ Eur Arch Otorhinolarygol. vol. 248, (1991) pp. 390-394. |
Hosemann, W. et al. ‘Behandlung nach Nasennebenhohleneingriffen, part 2: Theapeutische Maβnahem’ HNO akutell 7 (1999) pp. 291-302. |
Hospital Corpsman Sickcall Screener's Handbook. Naval Hospital Great Lakes (Apr. 1999) www.brooksidepress.org/Products/Operationa.Medicine/DATA. 2001 pp. 1-6. |
Hybels, R.L. ‘Transillumination Durning Osteoplastic Frontal Sinusotomy’ The Laryngoscope. vol. 91 (Sep. 1981) pp. 1560. |
Ijaduola, T.G.A. ‘Use of a Foley Catheter for Short-Term Drainage in Frontal Sinus Surgery’ Ther Journal of Laryngology and Otology. (1989) vol. 103. pp. 375.378. |
Ingals, E.F. ‘New Operation and Instruments for Draining the Frontal Sinus’ Ann. Otol. Rhinol. Layyngol. vol. 14 (1905) pp. 644-649. |
Iro, H. et al., ‘A New Device for Frontal Sinus Endoscopy: First Clinical Report’ Otolaryngol. Head Neck Surg. (2001) vol. 125 No. 6 pp. 613-616. |
Jacobs, J.B. ‘100 Years of Frontal Sinus Surgery’ Laryngoscope. vol. 107 (1997) pp. 1-36. |
K-Splints Internal Nasal Splints; Jan. 25, 2007; www.invotec.net/rhinology/ksplint.html. |
Kaiser, H. et al ‘Cortizontherapie, Corticoide in Klinik und Praxis’ Thieme, Stuggart (1992) pp. 390-401. |
Kennedy, D.W., M.D. et al. ‘Diseases of the Sinuses: Diagnosis and Management’ (Copyright 2001) by B.C. Decker Inc. |
Khomutov, S.M. et al. ‘Dissolution of a Mixture of Steroids in Cyclodextrin Solutions: a Model Description’ Pharmaceutical Chemistry Journal. vol. 35, No. 11 (Nov. 2001) pp. 627-629. |
Kingdom, T.T. et al. ‘Image-Guided Surgery of the Sinuses: Current Technology and Applications’ Otolaryngol. Clin. North Am. vol. 37, No. 2 (Apr. 2004) pp. 381-400. |
Klossek, J.M. et al. ‘Local Safety of Intranasal Trimcinolone Acentonide: Clinical and Histological Aspects of Nasal Mucosa in the Long-Term Treatment of Perennial Allergic Rhinitis’ Rhinology. vol. 39, No. 1 (2001) pp. 17-22. |
Kozlov et al. ‘Diagnosis and Treatment of Sinusitis by YAMIK Sinus Catheters’ Rhinology (1996) vol. 34, pp. 123-124. |
Kuhn, et al. ‘The Agger Nasi Cell in Frontal Recess Obstruction: An Anatomic, Radiology and Clinical Correlation’ Operative Techniques in Otolaryngology—Head and Neck Surgery. vol. 2, No. 4 (1991) pp. 226-231. |
Laliberte, F. et al. ‘Clinical and Pathologic Methods to Assess the Long-Term Safety of Nasal Corticosteroids’ Allergy. vol. 55, No. 8 (2000) pp. 718-722. |
Lang, E.V., et al., ‘Access Systems for Puncture at an Acute Angle’ J. Vasc. Interv. Radiol. (1995) vol. 6, No. 5, pp. 711-713. |
Lanza, D.C. ‘Postoperative Care and Avoiding Frontal Recess Stenosis’ International Advanced Sinus Symposium (1993) Jul. 21-24. |
Large, G.C. ‘Crystalline Tetracycline Hydrochloride in the Treatment of Acute and Chronic Maxillary Sinusitis’ Canad. M.A.J. (1958) vol. 79, pp. 15-16. |
Lund, V.J. ‘Maximal Medical Therapy for Chronic Rhinosinusitis’ Otolaryngol Clin N. Am. vol. 38 (2005) pp. 1301-1310. |
Maran, A.G.D. et al. ‘The Use of the Foley Balloon Catheter in the Tripod Fracture’ J. Laryngol. Otol. (1971) vol. 85, Issue 9, pp. 897-902. |
May, M. et al. ‘Frontal Sinus Surgery: Endonasal Drainage Instead of an External Osteopolstic Approach’ Op Tech Otolaryngo Head Neck Surgery. 6 (1995) pp. 184-192. |
Medtronic, xomed.com—MicroFrance Catalog Browser. www.xomcat.com/xomfrance/index.php?zone=both&cat=58&prodline=1272 (Dec. 31, 2003) pp. 1-2. |
Mehan, V.K. et al., ‘Coronary Angioplasty through 4 French Diagnostic Catheters’ Cathet. Cardiovasc. Diagn. (1993) vol. 30, No. 1 pp. 22-26. |
Mellor, J.M. et al ‘Synthesis of Trifluoromethylnaphthalenes’ Tetrahedron. vol. 56 (2000) pp. 10067-10074. Elsevier Science Ltd. |
Metson, R., et al., ‘Endoscopic Treatment of Sphenoid Sinusitis’ Otolaryngol. Head Neck Surg. (1996) vol. 114, No. 6 pp. 736-744. |
Metson, R. ‘Holmium: YAG Laser Endoscopic Sinus Surgery: A Randomized Controlled Study’ Laryngoscope. vol. 106, Issue 1, Supplement 77 (Jan. 1996) pp. 1-18. |
Miller, et al. ‘Management of Fractures of the Supraorbital Rim’ Journal of Trauma. vol. 18, No. 7 (Jul. 1978) pp. 507-512. |
Min, Y-G et al. ‘Mucociliary Activity and Histopathology of Sinus Mucosa in Experimental Maxilary Sinusitis: A Comparison of Systemic Administration of Antibiotic and Antibiotic Delivery of Polylactic Acid Polymer’ Laryngoscope. vol. 105 (Aug. 1995) pp. 835-842. |
Mols, B. ‘Movable Tool Tip for Keyhole Surgery’ Delft Outlook, vol. 3 (2005) pp. 13-17. |
Mooney, M.R., et al., ‘Monorail™ Piccolino Catheter: A New Rapid Exchange/Ultralow Profile Coronary Antioplasty System’ Cathet. Cardiovasc. Diagn. (1990) vol. 20, No. 2 pp. 114-119. |
Moriguchi, T. et al. ‘Additional-Elimination Reaction in the Trifluoroacetylation of Electron-Rich Olefins’ J. Org. Chem. vol. 60, No. 11 (1995) pp. 3523-3528. American Chemical Society. |
Nasal Surgery and Accessories, Jan. 25, 2007; www.technologyforlife.com.au/ent/nasal.html. |
Park, K. et al. ‘Biodegradable Hydrogels for Drug Delivery’ (1993) Technomic Publishing Inc. Lancaster. |
Piccirillo, J.F. et al. ‘Physchometric and Clinimetric Validity of the 20-Item Sino-Nasal Outcome test (SNOT-20)’ Copyright 1996 Washington University, St. Louis, MO. |
Piers, et al. ‘A Flexible Distal Tip with Two Degrees of Freedon for Enhanced Dexterity in Endoscopic Robot Surgery’ Proceedings 13th Micromechanics Europe Workshop (2002) pp. 271-274. |
Podoshin, L et al. ‘Balloon Technique for Treatment of Frontal Sinus Fractures’ The journal of Laryngology & Otology (1967), vol. 81. pp. 1157-1161. |
Pownell, P.H. et al., ‘Diagnostic Nasal Endoscopy’ plastic & Reconstructive Surgery (1997) vol. 99, Iss5 pp. 1451-1458. |
Prince, et al. ‘Analysis of the Intranasal Distribution of Ointment’ J Otolaryngol. vol. 26 (1997) pp. 357-360. |
Ramsdale, D.R., Illustrated Coronary Intervention: A case-oriented approach, (2001) Martin Dunitz Ltd. pp. 1-5. |
Ritter, F.N. et al., Atlas of Paranasal Sinus Surgery (1991) Igaku-Shoin Medical Pub. pp. 1-81. |
Robison, J. Mathews, M.D. ‘Pressure Treatment of Maxillary Sinusitis’ J.A.M.A. (May 31, 1952) pp. 436-440. |
Robison, J. Mathews, M.D. ‘Pressure Treatment of Purulent Maxillary Sinusitis’ Texas State Journal of Medicine (May 1952) pp. 281-288. |
Sama, A., et al., ‘Current Opinions on the Surgical Management of Frontal Sinus Disease’ ENT News. Www.pinpointmedical.com/ent-news (2009) vol. 17, No. 6 pp. 60-63. |
Sanborn, T.A. et al., ‘Percutaneous Endocardial Transfer and Expression of Genes to the Myocardium Utilizing Fluropscopic Guidance’ Catheter Cardiovasc. Interv. (2001) vol. 52, No. 2 pp. 260-266. |
Sawbones Catalog 2001, Pacific Research Laboratories, Inc., Vashon Washington 98070 USA. |
Saxon, R.R. et al., ‘Technical Aspects of Accessing the Portal Vein During the TIPS Procedure’ J. Vasc. Interv. Radiol. (1997) vol. 8, No. 5 pp. 733-744. |
Schaefer, S.D., M.D. ‘Rhinology and Sinus Disease: A Problem-Oriented Approach’ (Copyright 1988) by Mosby, Inc. |
Schneider, Pfizer Ad for Softip [date of publication unknown]. |
Shah, N.J. et al., ‘Endoscopic Pituitary Surgery—A Beginner's Guide’ Indian Journal of Otolaryngology and Head and Neck Surgery (2004) vol. 56, No. 1 pp. 71-78. |
Shah, N.J. ‘Functional Endoscopic Sinus Surgery’ (1999); found at bhj.org/journal/1999_4104_oct99/sp_659.htm. |
Single-Pole and Multi-Pole Lightguides for UV Spot Light Curing Systems. Www.dymax.com/products/curing_equipment/lightguids/light. (2004) pp. 1-2. |
Sobol, et al. ‘Sinusitis, Maxillary, Acute Surgical Treatment.’ eMedicine. Retrieved from the Internet: «http://emedicine.medscape.com/article/862030-print» (Nov. 16, 2010) pp. 1-11. |
St. Croix, et al., ‘Genes Expressed in Human Tumor Endothelium’ Science (May 15, 2000) vol. 289 pp. 1197-1202. |
Stammberger, H. ‘Komplikationen entzundlicher Nasennebenhohlenerkrankungen eischlieβ iatrogen bedingter Komlikationen’ Eur Arch Oti-Rhino-Laryngol Supple. (Jan. 1993) pp. 61-102. |
Stammberger, et al. Chapter 3 ‘Special Endoscopic Anatomy of the Lateral Nasal Wall and Ethmoidal Sinuses’ Functional Endoscopic Sinus Surgery. (1991) Ch. 3, pp. 49-87. |
Strom, et al. Die Behandlung von Stenosen der oberen Luftwege mittels rontgenologisch gesteurter Ballondilation (Sep. 25, 1999) pp. 1-4. |
Strohm, et al. ‘Treatment of Stenoses of the Upper Airways by Balloon Dilation’ Sudwestdeutscher Abstract 45 (Sep. 25, 1999) pp. 1-3. |
Suh, Paranasal Sinuses: Sagittal Anatomy with CT Images. http://ws.ajou.ac.kr/˜ent/mew/case_topic/RHINODATA/sagittalIPNS.htm. May 18, 1998. Accessed Feb. 20, 2015. |
SurgTrainer Product Information ‘Incisive Human Nasal Model for ESS Training’ Surg Trainer, Ltd. Ibaraki, Japan (2004) www1.accsnet.ne.jp/˜juliy/st/en/partslist.html. |
Tabor, M.H. et al., ‘Symptomatic Bilateral Duct Cysts in a Newborn—Rhinoscopic Clinic’ Ear, Nose & Throat Journal (2003) www.findarticles.com/p/articles/mi_m0BUM/is_2_82/ai_98248244 pp. 1-3. |
Tarasov, D.I. et al. ‘Application of Drugs Based on Polymers in the Treatment of Acute and Chronic Maxillary Sinusitis’ Vestn Otorinoloaringol. vol. 6 (1978) pp. 45-47. |
Terumo, Medi-Tech. Boston Scientific. (1993) Ad of Glidewire. |
The Operating Theatre Journal (www.otjonline.com) ‘Disposable Medical Device for Wound Disclosure/The Tristel Purple Promotion—A Collaboration between Tristel PLC and Karl Storz Ednoscopy (UK) Ltd.’ p. 4. |
Weber, R. et al. ‘Endonasale Stirnhohlenchirugie mit Langzeiteinlage eines Platzhalters’ Laryngol. Rhinol. Otol. vol. 76 (1997) pp. 728-734. (English Abstract). |
Weber, R. et al., ‘Videoendoscopic Analysis of Nasal Steroid Distribution’ Rhinology. vol. 37 (1999) pp. 69-73. |
Weiner, R.I., D.O., et al., ‘Development and Application of Transseptal Left Heart Catheterization’ Cathet. Cardiovasc. Diagn. (1988) vol. 15, No. 2, pp. 112-120. |
Wiatrak, B.J., et al., ‘Unilateral Choanal Atresia: Initial Presentation and Endoscopic Repair’ International Journal of Pediatric Otorhinolaryngology (1998) vol. 46, pp. 27-35. |
Woog, et al. ‘Paranasal Sinus Endoscopy and Orbital Fracture Repair’ Arch Ophthalmol. vol. 116 (May 1998) pp. 688-691. |
Wormald, P.J., et al., ‘The ‘Swing-Door’ Technique for Uncinectomy in Endoscopic Sinus Surgery’ The Journal of Laryngology and Otology (1998) vol. 112, pp. 547-551. |
Xomed-Treace. Bristol-Myers Squibb. Ad for Laser Shield II. Setting the Standards for Tomorrow. [date of publication unknown]. |
Yamauchi, Y. et al., ‘Development of a Silicone Model for Endoscopic Sinus Surgery’ Proc International Journal of Computer Assisted Radiology and Surgery vol. 99 (1999) p. 1039. |
Yamauchi, Y., et al., ‘A Training System for Endoscopic Sinus Surgery with Skill Evaluation’ Computer Assisted Radiology and Surgery (2001) with accompanying poster presentation. |
Yanagisawa et al. ‘Anterior and Posterior Fontanelles.’ Ear, Nose & Throat Journal (2001) vol. 80, pp. 10-12. |
Zimarino, M., M.D., et al., ‘Initial Experience with the EuropassTM: A new Ultra-Low Profile Monorail Balloon Catheter’ Cathet. Cardiovasc. Diagn. (1994) vol. 33, No. 1, pp. 76-79. |
Australian Office Action, Examiners First Report dated Apr. 8, 2010 for Application No. AU 2005274794. |
European Communication dated Sep. 4, 2008 for Application No. EP 05773189. |
European Communication dated Jun. 19, 2009 for Application No. EP 05773189. |
European Exam Report dated Feb. 22, 2006 for Application No. 02716734.5. |
European Exam Report dated Feb. 8, 2007 for Application No. 02716734.5. |
Supplemental European Search Report and Written Opinion dated Sep. 11, 2009 for Application No. EP 06815174. |
European Search Report dated Sep. 27, 2011 for Application No. EP 10182961. |
European Search Report dated Sep. 29, 2011 for Application No. EP 10182893. |
Partial European Search Report dated Sep. 20, 2007 for Application No. EP 07252018. |
Partial European Search Report dated Mar. 25, 2008 for Application No. EP 07252018. |
Supplemental European Search Report dated Jun. 2, 2008 for Application No. EP 05773189. |
Supplemental Partial European Search Report dated Jul. 1, 2009 for Application No. EP 06815285. |
Supplemental European Search Report dated Jan. 29, 2010 for Application No. EP 07836108. |
Supplemental European Search Report dated Feb. 2, 2010 for Application No. EP 07836109. |
Supplemental European Search Report dated Feb. 17, 2010 for Application No. EP 07836110. |
Supplemental European Search Report dated Mar. 1, 2010 for Application No. EP 05778834. |
Supplemental European Search Report dated Mar. 16, 2010 for Application No. EP 06718986. |
Supplemental European Search Report dated Jun. 22, 2010 for Application No. EP 06784759. |
Supplemental European Search Report dated Sep. 23, 2010 for Application No. EP 08746715. |
Supplemental Partial European Search Report dated Nov. 19, 2010 for Application No. EP 06751637. |
Supplemental European Search Report dated Jan. 28, 2011 for Application No. EP 07777004. |
Supplemental European Search Report dated Mar. 31, 2011 for Application No. EP 05798331. |
Supplemental European Search Report dated Aug. 30, 2011 for Application No. EP 06800540. |
Supplemental European Search Report dated Sep. 29, 2011 for Application No. EP 07750248. |
International Preliminary Report on Patentability dated Aug. 7, 2006 for Application No. PCT/US05/25371. |
International Preliminary Report on Patentability and Written Opinion dated Sep. 25, 2007 for Application No. PCT/US06/002004. |
International Preliminary Report on Patentability and Written Opinion dated Nov. 18, 2008 for Application No. PCT/US07/11449. |
International Preliminary Report on Patentability and Written Opinion dated Apr. 7, 2009 for Application No. PCT/US07/021170. |
International Preliminary Report on Patentability and Written Opinion dated May 5, 2009 for Application No. PCT/US06/36960. |
International Preliminary Report on Patentability and Written Opinion dated Oct. 13, 2009 for Application No. PCT/US08/059786. |
International Preliminary Report on Patentability and Written Opinion dated Oct. 27, 2009 for Application No. PCT/US08/061343. |
International Search Report dated Jun. 3, 2002 for Application No. PCT/EP02/01228. |
International Search Report and Written Opinion dated Apr. 10, 2006 for Application No. PCT/US05/25371. |
International Search Report dated May 8, 2007 for Application No. PCT/US2006/16026. |
International Search Report and Written Opinion dated Aug. 17, 2007 for Application No. PCT/US05/13617. |
International Search Report dated Aug. 29, 2007 for Application No. PCT/US06/002004. |
International Search Report dated Sep. 25, 2007 for Application No. PCT/US06/37167. |
International Search Report dated Oct. 19, 2007 for Application No. PCT/US07/03394. |
International Search Report and Written Opinion dated May 29, 2008 for Application No. PCT/US07/021170. |
International Search Report dated May 29, 2008 for Application No. PCT/US07/21922. |
International Search Report and Written Opinion dated Jul. 1, 2008 for Application No. PCT/US06/22745. |
International Search Report dated Jul. 3, 2008 for Application No. PCT/US2006/029695. |
International Search Report dated Jul. 7, 2008 for Application No. PCT/US07/16213. |
International Search Report dated Jul. 8, 2008 for Application No. PCT/US07/11474. |
International Search Report dated Jul. 17, 2008 for Application No. PCT/US06/36960. |
International Search Report and Written Opinion dated Jul. 21, 2008 for Application No. PCT/US05/33090. |
International Search Report dated Aug. 25, 2008 for Application No. PCT/US2008/000911. |
International Search Report dated Sep. 10, 2008 for Application No. PCT/US07/16212. |
International Search Report and Written Opinion dated Sep. 12, 2008 for Application No. PCT/US07/16214. |
International Search Report and Written Opinion dated Sep. 17, 2008 for Application No. PCT/US08/059786. |
International Search Report and Written Opinion dated Sep. 17, 2008 for Application No. PCT/US08/061343. |
International Search Report and Written Opinion dated Oct. 1, 2008 for Application No. PCT/US07/11449. |
International Search Report dated Oct. 15, 2008 for Application No. PCT/US2008/061048. |
International Search Report dated Nov. 30, 2009 for Application No. PCT/US2009/057203. |
International Search Report dated Dec. 10, 2009 for Application No. PCT/US2009/052236. |
International Search Report dated Dec. 15, 2009 for Application No. PCT/US2009/050800. |
International Search Report dated Mar. 31, 2010 for Application No. PCT/US2009/069143. |
International Search Report dated Jul. 8, 2010 for Application No. PCT/US2010/027837. |
International Search Report and Written Opinion dated Oct. 6, 2010 for Application No. PCT/US2010/040548. |
International Search Report dated Mar. 25, 2011 for Application No. PCT/US2010/062161. |
International Search Report dated Mar. 28, 2011 for Application No. PCT/US2010/061850. |
International Search Report dated Mar. 31, 2011 for Application No. PCT/US2010/060898. |
International Search Report dated Aug. 9, 2011 for Application No. PCT/US2011/038751. |
International Search Report dated May 18, 2012 for Application No. PCT/US2011/052321. |
International Search Report and Written Opinion dated May 15, 2014 for Application No. PCT/US2014/021842. |
International Preliminary Report on Patentability dated Sep. 15, 2015 for Application No. PCT/US2014/021842. |
USPTO Office Action dated Sep. 16, 2005 for U.S. Appl. No. 10/259,300. |
USPTO Office Action dated Jul. 7, 2006 for U.S. Appl. No. 10/259,300. |
USPTO Office Action dated Feb. 13, 2007 for U.S. Appl. No. 10/259,300. |
USPTO Office Action dated Oct. 9, 2007 for U.S. Appl. No. 10/259,300. |
USPTO Office Action dated Jan. 24, 2008 for U.S. Appl. No. 10/259,300. |
USPTO Office Action dated Oct. 6, 2008 for U.S. Appl. No. 10/259,300. |
USPTO Office Action dated May 29, 2007 for U.S. Appl. No. 10/912,578. |
USPTO Office Action dated Nov. 14, 2007 for U.S. Appl. No. 10/912,578. |
USPTO Office Action dated Dec. 10, 2007 for U.S. Appl. No. 10/912,578. |
USPTO Office Action dated Oct. 18, 2007 for U.S. Appl. No. 11/037,548. |
USPTO Office Action dated Dec. 6, 2007 for U.S. Appl. No. 11/037,548. |
USPTO Office Action dated Apr. 9, 2008 for U.S. Appl. No. 11/037,548. |
USPTO Office Action dated Nov. 28, 2007 for U.S. Appl. No. 11/234,395. |
USPTO Office Action dated Sep. 12, 2008 for U.S. Appl. No. 10/829,917. |
USPTO Office Action dated Nov. 17, 2008 for U.S. Appl. No. 10/829,917. |
USPTO Office Action dated Mar. 18, 2009 for U.S. Appl. No. 10/829,917. |
USPTO Office Action dated Nov. 9, 2009 for U.S. Appl. No. 10/829,917. |
USPTO Office Action dated Oct. 29, 2008 for U.S. Appl. No. 11/347,147. |
USPTO Office Action dated Feb. 4, 2009 for U.S. Appl. No. 11/347,147. |
USPTO Office Action dated Aug. 6, 2009 for U.S. Appl. No. 11/347,147. |
USPTO Office Action dated Nov. 7, 2008 for U.S. Appl. No. 10/944,270. |
USPTO Office Action dated Jan. 28, 2009 for U.S. Appl. No. 10/944,270. |
USPTO Office Action dated Apr. 21, 2009 for U.S. Appl. No. 10/944,270. |
USPTO Office Action dated Nov. 17, 2008 for U.S. Appl. No. 12/117,582. |
USPTO Office Action dated Mar. 3, 2009 for U.S. Appl. No. 12/117,582. |
USPTO Office Action dated Aug. 6, 2009 for U.S. Appl. No. 12/117,582. |
USPTO Office Action dated Nov. 17, 2008 for U.S. Appl. No. 12/118,931. |
USPTO Office Action dated Mar. 4, 2009 for U.S. Appl. No. 12/118,931. |
USPTO Office Action dated Jul. 30, 2009 for U.S. Appl. No. 12/118,931. |
USPTO Office Action dated Nov. 25, 2008 for U.S. Appl. No. 12/117,961. |
USPTO Office Action dated Aug. 6, 2009 for U.S. Appl. No. 12/117,961. |
USPTO Office Action dated Dec. 5, 2008 for U.S. Appl. No. 12/120,902. |
USPTO Office Action dated Oct. 21, 2009 for U.S. Appl. No. 12/120,902. |
USPTO Office Action dated Mar. 17, 2009 for U.S. Appl. No. 11/960,127. |
USPTO Office Action dated Mar. 23, 2009 for U.S. Appl. No. 11/804,309. |
USPTO Office Action dated Nov. 17, 2008 for U.S. Appl. No. 11/926,326. |
USPTO Office Action dated Aug. 28, 2009 for U.S. Appl. No. 11/150,847. |
U.S. Appl. No. 11/789,705, filed Apr. 24, 2007. |
U.S. Appl. No. 13/832,167, filed Mar. 15, 2013. |
U.S. Appl. No. 13/837,104, filed Mar. 15, 2013. |
U.S. Appl. No. 14/038,867, filed Sep. 27, 2013. |
U.S. Appl. No. 14/197,436, filed Mar. 5, 2014. |
U.S. Appl. No. 60/844,874, filed Sep. 15, 2006. |
U.S. Appl. No. 60/922,730, filed Apr. 9, 2007. |
U.S. Appl. No. 61/052,413, filed May 12, 2008. |
U.S. Appl. No. 61/084,949, filed Jul. 30, 2008. |
U.S. Appl. No. 61/725,523, filed Nov. 3, 2012. |
Number | Date | Country | |
---|---|---|---|
20170273747 A1 | Sep 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14197436 | Mar 2014 | US |
Child | 15484542 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14038867 | Sep 2013 | US |
Child | 14197436 | US | |
Parent | 13837104 | Mar 2013 | US |
Child | 14038867 | US |